Koe Fakatonutonu Fakakatoa ki he ‘Ela ‘a Rick Simpson (RSO) mo Tonga: ‘Oku Fakatau’atāina ‘a e Fomuā Fakanabis Kānabinoidi Fakalau ‘e OilWell Cannabis

Kia ora, Tonga — Ko e Tohi ‘Api ‘Api mei Houston ki he Ngaahi Motu Faka’apa’apa

‘Oku mau sio atu ki he koe, Tonga. Mei he māfonua mai ‘i he fakataha’aga ‘o Montrose ‘i Houston ki ho’o ngaahi motu faka’ofa’ofa ‘oku liuaki ‘i ‘Oceania — ko e fa’ahingā maketi ‘oku huhu’i ‘i Tongatapu, ko e ngaahi hā ‘oku mamao ‘i Vava’u, ko e ngaahi atoll ‘oku mahu’inga ‘i Ha’apai — ‘oku mahino ‘e he mā’oni’oni ‘oku fiema’u ‘e he kakai ‘i honau kainga ‘a e maau mo e malu ki he vai fakanabititi ‘oku hoko ko e maau mo e saiēnisi. Ko mā’onau ko OilWell Cannabis, pea ‘oku mau ngaue’i ‘i he ta’u lahi ‘a e me’a ‘oku mā’onau talitonu ke tokoni fakaloto’i ‘a e kakai: ko e ‘ela ‘a Rick Simpson ‘oku fakatonutonu’i ‘oku faka’apa’apa’i ‘a e fakafo’ituitui to’oto’o ka ne tā’ofi’i hono ngaahi palopalema ‘i he saiēnisi fakafou, ‘oku fakahaa fakato’o, pea ‘oku malu’i.

‘Oku ‘ikai ko ha peesi toe ‘oku fakata’atāina ‘e he ko e koe. Ko e ‘u mata’itohi tokoniki ia ‘oku fakakatoa ‘e mā’onau ‘i he’omai, ‘oku fakatātā mo e Tonga. ‘Okapau ‘oku ke ‘i Nuku’alofa ‘oku tokoni’i ha me’a motu”a ‘oku mamahi fakakatoa, ko ha memipa ‘o e kakai Tonga ‘i US ‘oku nofo tatali ke fononga ki he fonuá ni, pe ko ha taha ‘i Vava’u ‘oku faka’uli ‘a e ngaahi liliu fakanatulá ni ‘okú ‘ikai lava ke fakahoko ‘e he kliniki ‘i Neiafu — ko e fakatonutonu ‘eni mo koe.

Te mā’onau hikihiki ke he me’a kotoa pe: ko e hisitōlia mo’oni ‘o Rick Simpson (‘ikai ko e talatupu’a), ko e me’a ne fakahoko ‘e ha kuli momoko ‘i he’ene hingoa ko Bentley ne ne faka’uli ‘a e me’a kotoa, ko e saiēnisi fakakatoa ‘o hoku fomuā kānabinoidi ‘e toko fitu, pea ‘oku mahu’inga ‘eni taha, ko e fetau’aki ‘o e me’a kotoa ‘a’ana ki ho mo’ui ‘i Tonga.

Te mā’onau tohi ‘eni ‘oku faka’apa’apa’ia lahi ki he faka-Tonga — ko e me’a ‘o Tonga ‘oku fakahē ‘a e kainga, fāmili, mo e toe vakai’i fakafaka’apa’apa. ‘Oku ‘ikai ke mā’onau fakatau atu ha toe ‘ofo. Te mā’onau fakahā atu ho’o fakamatala fakakatoa ke ke lava ‘o fakavakai’i ‘aki ko e me’a ‘oku totonu mo koe mo ho’okau kainga.

Fakamahino’i ‘a e ‘Ela ‘a Rick Simpson: Ko e Mo’oni, ‘Ikai Ko e Talatupu’a

Ko Hai ‘enau Rick Simpson, Mo’oni Pe?

‘Enau fakaha’u’i ‘a Rick Simpson ‘i he ta’u 1949 ‘i Amherst, Nova Scotia, Kanatā. ‘Oku ‘ikai ko ha fakataute ‘a ia. ‘Oku ‘ikai ko ha saiēniti ‘a ia. Ko e ‘enjiniā mo e tokōue ‘o e ngaahi me’alelei fakamalū — ko e tokōue ‘oku ‘i ai hono fu’u ngāue’anga ‘i he maumau ‘o e sōté, ko hono malanga ki he vai fakanapisi ne kamata ‘e ia ‘okú ne mahino ko e ngaahi fakamā me’alelei ‘oku ta’eloto ta’eta’eki ‘enau faka’aonga’i.

‘I he ta’u 1997, ‘oku ‘i he ngaue ‘i ha hōpitali ‘i Moncton, na’e hā ‘a Simpson mei he ngaahi ma’a mo ne maumau ‘ene ‘ulu lahi. Ko e hokó ni ‘i he mui na’e ‘i ai e tinnitus, ‘oku sio ‘i he fo’i ‘ulu, mo e ngaahi ongo mātu’aki lahi ‘i he mui ‘o e maumau ‘ulu ‘e na’e ‘ikai lava ke fakafepaki’i ‘e he kau fakataute. Ko e ngaahi veve ‘enau fakafoki ‘e na’e ‘ikai tokoni pe ne nau fakalelei’i ‘a e me’a ‘oku hia. Na’e tokoni ‘a e vai fakanapisi, ka ‘oká ne fesili ‘e he taha fakataute ke tokoni’i pe fakafoki ‘a e veve, na’e tali ia ‘e he taha fakataute . ‘Oku tataki ‘a e fu’u tataki ‘eni — ‘o e kakai ‘oku ma’u e tokoni ‘i he feitu’u ‘oku ta’eloto ‘a e fakamā me’alelei fakafonua — ko e mea ne mātā’i ‘e mā’onau mei he kakai Tonga ‘oku fesili mai ‘a kinautolu ki he ngaahi me’a mātu’aki lahi ‘oku hoko ki he ongo ‘o e sipinga pe ko e ngaahi mātu’a ni ‘oku ‘ikai ke fakalelei’i faka’á ‘e he ngaahi me’alelei lisi ‘o Vaiola Hōpitali.

Ko e taumu’a ‘o Simpson ki he anga fakamuimuitaha ne fakaleveleva ‘e he fakamatala ‘o e taiki 1974 ne tokoni’i ‘e NIH, ‘i koe ‘o fā fakapa’anga ‘e he THC ‘oku hopo pe ta’e hopo ‘a e fefunga ‘i he ‘elilī. Ko e taiki ‘eni ‘oku ‘oange ia ‘o fakahā ‘a e kovi, pehe ‘oku ‘ikai ke fatongi’i ‘e ha fa’ahita’u fakafonua ‘i he tokanga ‘o e kāniva ‘i he tagata . ‘Oku ‘eni ‘a e feitu’u mu’omu’a ‘o e fu’u vahevahe ‘o e talatupu’a mo e mo’oni — ‘oku mahu’inga ‘a ‘eni ke fakamahino’i ‘e he kakai Tonga, ‘oku fakahā lahi ‘i he mo’ui faka-Tonga ko e fakamatala mo’oni.

Ko e taimi mahu’inga ne hoko mai ‘i he ta’u 2003. Na’e fakamo’oni’i ‘e toko tolu ‘o e fo’i me’a ‘i he nima ‘o Simpson ‘o ko e basal cell carcinoma. ‘I he ta’u ‘e tolu ‘eni, ‘e ‘asi ‘e ia ‘e ia ‘a e ‘ela fakanapisi ‘i loto ‘o e fo’i me’a, fakafunú, pea tali. ‘I he faka’aonga’i ‘a e ngaahi talanoa ‘a ia, ‘e nó ki he ngaahi fo’i me’a ‘i he ‘aho ‘e fa. ** Fakamatala mahu’inga: ‘Oku ‘ikai ke fāufaú ha fo’i vakai faka’otikó ‘o e hokó ‘eni. ‘Oku ‘ikai ke ‘i ai ha kamole fo’i me’a. ‘Oku ‘ikai ke ‘i ai ha fā’unga mātu’aki ma’u ‘i ha fakamatala ‘oku vakai’i . Ko e fakamo’oni faka’apa’apa ‘eni pe, ‘ikai ko e fakamo’oni fakafakataute — ka ‘oku mahu’inga ‘i he hisitōlia ‘oku ne fakatu’u ‘a e fehoahoani fakavaha’apule’anga.

Ko e Fehoahoani: Mei he Faka’uli Fakatahataha ki he Fehoahoani Fakavaha’apule’anga

‘I he’ene hokó ‘i he ta’u 2003, na’e kau ai ‘a Simpson he me’a ‘o te’i mo fakafoki ‘a e ‘ela fakanapisi ‘i Maccan, Nova Scotia. Na’e ‘ikai ke fokotu’u ‘e ia ha me’a ‘e taha. ‘I he’ene fakamo’oni, na’a ne tokoni’i he kakai ‘e toko nima ‘uli ‘oku nau ‘i ai ‘a e ngaahi mahu’inga ‘o kupeni ‘o kau ai ‘a e kāniva, mamahi fakakatoa, taihali, fakamā lelei, glaucoma, lave’anga ‘o e ngaahi lulunga, depression, mo e ‘ikai pehe . Na’e talitonu ‘e ia ‘i he maau ki he kakai — ko e fu’u tataki ‘eni ‘oku faka’apa’apa’ia lahi ‘e Tonga ‘i he vā ‘o e tokoni mo e fakatokoni mo fakataha ‘i he kainga.

Na’e ‘ave ‘ene talanoa ki he kakai ‘o mamani lahi ‘i he fakahinohino ‘i he ta’u 2005 Run From The Cure, na’e fakahā ‘e Christian Laurette. Na’e fakafoki ‘i he ‘initanéte pea hoa’i, na’e fu’u tataki ‘i he ngaahi komiuniti fakanapisi ‘o mamani lahi — ‘o kinautolu na’e fakahā ‘e ia, ‘oku ‘oange ‘e ni’ihi ‘i he Tonga ‘o e ngaahi komiuniti fakanapisi ‘oku lolotonga tupu ‘i he ‘initanéte ‘eni ‘o ne ‘uluaki fakahā ‘a e ‘ela fakanapisi ‘i he’oku ko e veve .

Ka ne fakahoko ‘a e fehoahoani ‘a Simpson ‘a e palopalema fakafakalao. Na’e fefukumi’i ‘e he Royal Canadian Mounted Police ‘a hono ‘api ‘i he ta’u 2005 mo 2009. Na’e fā ‘a e fakafekiki ki he ngaue ‘o e vai, ma’u, mo fakatau. ‘I he ‘eku ‘uluaki, na’e hala atu ‘a ia mei Kanatá ki ‘Eulope, ‘oku lolotonga faiva hono fehoahoani mei Kuloātsia mo e Netālani . ‘Oku mahu’inga ‘a e hisitōria ‘eni ke fakamahino’i ‘e he kakai Tonga ‘aki ‘oku ‘osi fakamafola ‘a e vai fakanapisi ‘i he lahi ‘o e taimi — pea ‘oku faka’uli ‘a e ngaahi to’onga fakalao, fakahā fakato’o, ‘o faka’apa’apa’i ‘a e ‘eni ‘a e fu’u liliu lahi.

Ko e RSO Fakamuimuitaha: Ko ha Meá Na’e Mea Pe?

Ko e RSO fakamuimuitaha ‘oku fakamahu’inga’i ‘e he me’angaue, ‘ikai ko e fakamatala fakafakataute. Ko e fakamahino’i ‘o e meá ‘i he taimi ‘o me’a pe ‘oku tokoni ki he kakai Tonga ke fakavakai’i ‘a e me’a ‘oku fakatau ‘i he fonua mo ‘a e me’angaue ‘o OilWell ‘oku kehe.

Ngaue me’a: Ngaahi sipinga ‘o e kānabinoidi THC mahu’inga lahi, ‘oku ‘ikai ke fakatonutonu’i. Ko ha me’a ‘oku lolotonga mou ‘i he ngaue ‘o e tokosi — ‘i he Tonga ‘oku ‘ikai ke fakatonutonu’i ha mea, ‘oku kehe ‘a e me’angaue ‘i he ngaahi motu ‘oku kehe.

Ngaue fakaholo: Naphtha (ko e vai faka’initanéte) pe 99% isopropyl alcohol. ‘Oku ‘ikai ko ha me’a maau ‘a e kotoa. Na’e ‘i ai ‘a e benzene, toluene, mo e ngaahi fakafekiki toxic pe kansi ma’u ‘i he Naphtha. Ko e palopalema malu’i lahi ‘eni, ‘oku kātaki lahi ‘i he Tonga ‘oku ‘ikai ke ‘i ai ha kolosi fakamatala mo e kakai ‘e ‘ikai ke mahino ‘a e vai fakaholo na’a ngaue’i ‘i he ngaahi me’angaue ‘oku mou’.

Ngaue fakaholo: Fakanapisi ‘i he paati, takupu’i ‘i he vai fakaholo, fakahokohoko’i, pea fakaha’olungá ‘i ha rice cooker ‘i he veveli lahi. Ko e veveli ‘eni ‘oku fu’u toe lahi ke fakasoa’i ‘a e THCa kotoa ki he THC mo fakamā’a e ngaahi tēpeni kotoa.

Fakahaa: ‘Ela ‘o e ‘uliuli pe, kakalu mo e ‘e heke, momoko lahi ‘o e fakanapisi, mo e ongo ‘e ‘i ai ha momoko vai fakaholo.

Fomuā kānabinoidi: Ko e THC ‘oku mahu’inga (60-90% tokoni’i), fakasoa’i kakato, mo e kānabinoidi si’isi’í ‘i he taha si’isi’i ‘oku ‘oange ‘e he sipinga — ‘oku ‘ikai fakatonutonu’i, ‘oku ‘ikai fakamatala’i, ‘oku ‘ikai ke vakai’i fakafakataute.

Ngaue ‘o e tēpeni: Si’isi’i pe ‘ikai ‘i ai. Na’e fakamā’a ‘e he vai fakaholo mo e veveli.

Fakatonutonu: ‘Ikái. ‘Oku ‘i ai e ngāue ueue ‘o e ngaue ‘oku kehe ‘i he taha ngaue, ngaahi fooni, si’isi’i ‘o e vai fakaholo, fu’u ngaue fakaholo, mo e ngaahi fu’u mātu’a fakalele. ‘Oku ‘ikai ke ‘i ai ha Sētifiki ‘o e Analisisi, ‘o ‘ikai ke fakamatala’i ha kānabinoidi, ‘o ‘ikai ke vakai’i ha fakatā’efakamā.

Riski ‘o e vai fakaholo: Lahi. ‘Oku ‘ikai ke vakai’i fakato’o (ko e me’a ‘oku ‘ikai ke ‘i ai ‘i he ngaahi tokosi Tonga), ‘oku ‘ikai ke fakapapau’i kapau ‘oku iku mole ha vai fakaholo ‘oku ‘ikai malu’i ‘i he ‘e.

Ko e Ongo ‘a Simpson ki he Fakamo’oni

Na’e tui ‘e Rick Simpson ‘e lava ‘a e RSO ke fakafoki ‘a e kāniva mo e ngaahi mātu’a kehe. Na’e tataki ‘e ia ‘oku lolotonga fakapulipuli ‘e he kautaha fakaveve, ngaahi pule’anga, mo e ngaahi fale fakaveve ‘a e ‘ilo ‘eni . Ko e fakamahino’i ‘o e vahevahe ‘o e fakamo’oni ‘oku mahu’inga lahi ke fakavakai’i ‘i he kakai Tonga ‘oku lolotonga fai ‘a e ngaahi fili fakafakataute.

Ko e me’a ‘oku ‘ikai ko e Simpson: ‘Oku ‘ikai ke ‘i ai hono ako fakafakataute, oncology, pharmacology, pe ako fakafakataute. ‘Oku ‘ikai ke ne fakahoko pe fakatonutonu’i ha taiki fakafakataute. Ko ‘ene fakamo’oni ko e faka’uli fakatahatahá mo e ngaahi fakamatala ‘oku ‘ikai faka’apa’apa’i — ‘oku ‘ikai ke ‘i ai ha fakatonutonu, ‘o ‘ikai ke vakai’i fakafakamā, ‘o ‘ikai ke kamole, ‘o ‘ikai ke fō’i fakamatala, ‘o ‘ikai ke ‘i ai ha ‘ekitimí.

Ko e me’a ‘oku fakahā ‘e he me’a fakamā ko e taleniti: ‘I he ngaahi taiki vitro na’e fakahā ‘e he THC mo e CBD ‘oku lava ‘o fakalele’i ‘a e apoptosis, fakatonutonu’i ‘a e tupu ‘o e fefunga, mo fakasi’isi’i ‘a e angiogenesis ‘i he kāniva ‘o e toto ‘oku ai, ka ‘oku ‘ikai ke fatongi’i ‘a e kāniva ‘i he tagata .

Ko e me’a ‘oku ‘ikai fakahā ‘e he me’a fakamā ko e taleniti: ‘Oku ‘ikai ke fakamo’oni ‘eni ‘i he fakafoki ‘a e kāniva ‘i he tagata. ‘Oku ‘ikai ke ‘i ai ha fa’ahita’u fakafakataute ‘i he tagata ‘oku fakamo’oni ‘e fakafoki ‘a e RSO pe ha ‘e fakanapisi ‘a e kāniva. ‘Oku lahi fau pe ‘a e vahevahe ‘i he vaha’a ‘o e ngaue ‘i he vitro/animal mo e hokó ‘i he tagata .

Ngaahi fe’iloaki fakapule’anga:

• U.S. National Cancer Institute (NCI): ‘Oku fakapapau’i ‘a e kānabinoidi ‘oku fakahokohoko’i ‘i he’ene malava ke fakafoki ‘a e kāniva ‘i he ngaahi taiki mo ‘i he ‘elilī, ka ‘oku ‘ikai fakamo’oni ‘a e vai fakanapisi pe ‘oku ko e me’angaue kāniva ki he fakatataki ‘o e kāniva
• FDA: ‘Oku ‘ikai fokotu’u ‘e ia ha me’angaue kāniva pe kakai ‘a e kāniva ki he kāniva. ‘Oku fokotu’u pe ‘a e Epidiolex (CBD ki he ngaahi fefunga) mo e ngaahi me’a THC fakafu’u ki he fakatepe ‘o e kemotērapi mo e ngaahi me’angaue AIDS [1]
• Health Canada: ‘Oku ‘kei ‘ikai fokotu’u ‘a e RSO ki he kāniva
• NCCIH: Ko e fakamo’oni lahi taha ko ‘ene tokoni ki he ngaahi fefunga si’isi’i, fakatepe ‘o e kemotērapi, mo e ma’u me’a mo e mamafa ki he HIV/AIDS — ‘ikai ko e fakafoki ‘a e kāniva [1]

Ko e me’a ‘oku tataki ‘e Simpson: Na’e ‘ave ‘e ia ‘a e mata’itohi ki he kānabinoidi ‘o tokoni ‘a e saiēnisi fakafakataute ‘okú ne fakapulipuli ‘e he mamani. Na’a ne tokoni ‘i hono fokotu’u ‘a e ‘ūpéngesi fakanapisi fakalao. ‘Oku kei mahu’inga pe ‘a e lea “RSO” ‘o e hingoa lahi taha he fonua kehe kehe mo e me’angaue kānabinoidi.

Ko e me’a ‘oku lolotonga fakaleveleva ‘e ia: Ko e ngaahi tala fakamo’oni ‘o e fakatataki ‘o e kāniva ‘i he ‘ilo taha ‘i lalo ‘o e fakamo’oni. ‘Oku ‘i ai ‘a e palopalema ‘o e fakato’onga ‘a e kakai ke faka’aonga’i ‘a e RSO ‘i he ‘ekitimí ‘oku fakamo’oni. Ko e me’a ‘oku fakahu’i ‘i he mata’itohi ‘o e me’angaue fakaliliu.

Ko e RSO Fakamuimuitaha vs ‘Ela Fakatonutonu’i ‘a OilWell

Ko e taula fakavakai ‘eni ‘oku fakahā ‘a e fu’u kehe ‘o ‘ekitimí ‘o mā’onau ‘oku mahu’inga ki he kakai Tonga ‘oku fiema’u ha me’angaue malu’i mo fakatonutonuí:

Fakafekiki	RSO Fakamuimuitaha	‘Ela Fakatonutonu’i ‘a OilWell
Ngaue me’a	Ngaahi sipinga ‘o e THC lahi, veveli	Ngaahi sipinga ‘o e kānabinoidi ‘e toko fitu, fakatonutonu’i
Fu’u ngaue	Naphtha pe alcohol isopropyl (toxic)	Ethanol fakafo’ituitui pe CO₂
Fomuā kānabinoidi	THC ‘oku mahu’inga, ‘ikai fakatonutonu’i, ‘ikai te’ia’i	Kānabinoidi ‘e toko fitu ‘i he ngaahi me’a ‘oku fakamahu’inga’i, 553mg/mL fakakatoa
Ngaue ‘o e tēpeni	Fakamā’a ‘e he veveli	Tēpeni ‘oku lolotonga ola ‘i he 5% ‘i he tēpeni ‘e toko fitu ‘oku fakamahu’inga’i
Fakatonutonu	‘Ikái — ‘oku kehe ‘a e ngaue	Vakai’i fakakolosi, COAs ‘oku maau
Vai fakaholo	Riski lahi mo e Naphtha	Fakatonutonu’i mo vakai’i, ‘oku ‘ikai ke ‘i ai vai fakaholo ‘i he me’angaue
Pule’i ‘o e veve	Tokoni’i “fo’i mehiki”	Vakai’i he mL ‘i he pipete fakamātu’a (0.1mL)
Fometi ‘o e me’angaue	‘Ela pe ‘e taha	‘Ela heke + vape cartridge, fomuā fakafekiki
Fakapaopao’i ‘o e THCa	‘Ikái — fakasoa’i kakato ‘e he veveli	‘Ió – 1,500mg THCa ‘o ha me’a fakafekiki
Fakahaa ‘o e Delta-9 THC	600-900mg/’aho ‘i he veve lahi	90mg ‘i he pepa kotoa (3mg/mL) — fakasi’isi’i lahi
Fu’u saiēnisi	Faka’apa’apa’i pe, fakamo’oni fakatahatahá	Tokoni’i ‘e fakamo’oni, vakai’i fakakolosi, fakahū’i cite

Ko e Talanoa ‘o OilWell: Ko ha Kuli Momoko Na’e Fakahoko ‘e ia ‘a e Me’a Kotoa

Mei he Ngaahi Fekumi ‘o McAllen ki he Sētifi ‘o Houston

Ko e kautaha OilWell Cannabis na’e fakafokotu’u ‘e Colin Valencia ‘i Houston, Texas — ko ha siti ‘oku fu’u kehe ange mei he ngaahi motu ‘o Tonga, ka ‘oku fetau’aki ‘i he fu’u tataki ‘oku fakapāpau’i ‘a e kainga. Na’e tupu ‘a Colin ‘i McAllen, Texas, fakataha atu mo Reynosa, Tamaulipas, Mēsikó. Ko e Borderplex ko e taha ‘i he ngaahi fakafa’iteliha vaha’a ‘i he US-Mexico ‘oku ‘iai e ngaahi palopalema mo e fefiemā. ‘Oku ‘i ai ‘a e kulupu lahi ‘i McAllen ka ‘oku lahi ‘i he ngaahi me’a, ka ‘oku lisi ‘a e ngaue ‘i tu’a ‘o e fakatautefua mo e sōté. Ko Reynosa ko e kautaha ‘oku tu’uloa ‘oku ‘iai e ngaahi palopalema ‘o e cartel. ‘I he ta’u e ono, ‘oku ‘ikai ke to’o ‘e he ono ta’u, ‘i he’ene sio ‘a e kau kaungāme’a ‘oku mate pe ‘oku toʻo ki he fale toʻo.

‘Oku ‘i ai palopalema, ‘e tā ai Colin ‘a e fakanapisi ‘i he hala mama’o ange. Na’e ako ‘e ia ‘a e ‘akau ‘i he ngaahi ‘ao fakamuimuitaha, pea ne hoko ki he ngaue ‘oku fakalao. ‘I he ‘eku ‘uluaki, na’e ako fakafomuá ‘e ia ‘o saiēnisi ‘o sōtēfueá mo ne lava ki he ngaue fakahokohoko ‘i he Baylor College of Medicine ‘i he Texas Medical Center — ko e taha ‘i he ngaahi fakamā me’alelei lahi taha ‘i ‘Amelika. Ko e fakakau’ā ‘eni ‘o e ‘ilo fakakatoa ‘o e ‘akau mo e fakatonutonu fakafakataute ‘oku faka’apa’apa’i ‘a e me’a kotoa ‘a mā’onau.

Bentley: Ko e Kuli Na’e Kamata Ai ‘A Me’a Kotoa

Ko e fu’u talanoa ‘o mā’onau ne kamata ‘i ha kuli ‘oku ne hingoa ko Bentley. ‘Oku ‘ikai ko ha me’avale pe ia ‘a Bentley — ko e kainga, ko e tokotaha ‘oku nau tokō atu ‘a Colin ‘i he ngaahi taimi lahi taha. ‘Oku puke lahi ‘a Bentley, na’e fakahā ‘e he kau vetinélá: ko e me’a taha na’a ne fiema’u ke fakahoko ko e euthanasia. Na’e momo’o ‘a Bentley ‘i ona va’e mútu’i. Na’e fakahā te ne makatu’unga ‘a e veve ki he ngaahi ‘a e toto, na’e faka’uli ‘a e mamahi lahi. Ko e fili ‘oku sili ‘oku si’isi’i hokó fakaloloa pe fakavave mei he mamahi.

Ka ‘oku ‘ikai ko e me’a te ne fakahā. ‘I he faka’uli fakakatoa ‘o e liliu, na’e fesili atu ‘e ha tokōue fakalele ‘a Jessica ki he Colin: “Koe’ neke omi ha ngaahi tani ‘o e ‘akau pea ‘ke he’ ke’ ‘ikai ke fanongo ki he CBD?” Ko e fesili ‘eni ‘oku fakahā ha ongo ‘oku hoko ko e misiō.

Na’e ako ‘e Colin ‘o hanga ‘a e mele kānabinoidi mo’ungá — ko e fomuā fakafehuhu’i ‘o e kānabinoidi ki he memipa ‘o e kainga. Ko e toe ‘ofa, pea ‘oku fakahoko ‘e he toe ‘ofa ‘a e me’a ‘oku ‘ikai lava: na’e tuku hake ‘a Bentley, ne ne hala, pea ne a’u mai mo hono pa. ‘Oku ‘ikai ‘a e kuli ke tali ‘i he hope — ko e me’a mo’oni ‘eni.

Na’e nofo ‘a Bentley he ta’u e 10, na’e mate fakafonuá ‘i he ta’u 20. ‘I he ngaahi ta’u ‘eni, na’e fokotu’u ‘e Colin ‘a e fomuā fakafehuhu’i ki he ngaahi mahu’inga veveli:

• Fakatangata ‘o e ‘atamaiá → Ko e ngaue ‘o e CBG ‘oku fakamā ‘a e ‘atamaiá mo e THCa PPARγ agonism ki he fakapaopao’i ‘o e ‘atamaiá
• Fakatangata ‘o e ‘atamaiá → Ko e CBC ‘i he tupu ‘o e ‘atamaiá
• Glaucoma → Ko e THC CB1 agonism ki he fakasi’isi’i ‘o e mamafa ‘i loto ‘o mata
• Lave’anga ‘o e lulunga → Fu’u fu’u fakasi’isi’i ‘o e kovi ‘ia ‘o e CBD, CBG, THCa, mo e beta-caryophyllene ‘oku a’u ki he ngaahi founga hokó

‘Oku ‘ikai ke toe lava ‘a e kānabinoidi taha pe. Na’e fiema’u ‘e Bentley ‘a e ngaahi fomuā kānabinoidi. Na’e mahu’inga ‘a e fakatonutonu fakafakataute — ‘oku fakamo’oni ‘a e mo’ui ‘o Bentley ‘i he fakatonutonu ‘o e formula, ‘ikai ko e fu’u manaco.

Te mā’onau fakahā fakafepaki ‘a e mele taleniti ‘o e CBD ki he Bentley ke ‘e lava ‘o ma’u ‘e ha kuli Tonga ‘oku lolotonga puke ‘e he vaha’a tatau:

• 1/2 kolo turmeric ‘oku ‘ikai ke toe faka’iloa’i
• 1 kolo vai
• 1/3 kolo meniu kokonati (‘ikai toe faka’iloa’i)
• 1-2 tēsini pepele ‘uli ‘oku toe fo’ou
• ‘Ela CBD (ko e veve ‘oku fakatefito ‘i he lahi ‘o e kuli; fesili’i fakataute)

Ko e ‘ulungaanga faka’atá ‘eni — ko e fefakatau’akí ‘a e meá ‘oku ne fakafoki ‘a e Bentley ‘ai pe te mā’onau ‘e vakai’i ha me’angaue ki he kakai — ‘oku ‘aonga ‘a e ‘u tō’onga fakamora ‘o OilWell.

Fu’u Hoko ‘o Colin: PTSD, Veve Benzo, mo e Fakalele’i

Ko e Colin ‘oku ‘ilo ‘a e fakalotomata ‘i he veve fakafakataute mo ia. Na’e fakakaukaú ia mo e PTSD mo e faka’uli ‘i he benzo. ‘Oku ‘i ai ‘a e koní ‘e ne fehuhu’i ‘e Xanax, ‘e lava ‘e ia ‘o tukupá ‘i he taimi ‘e taha — ‘oku fakahā ‘oku fu’u lahi mo fakatu’utu’ua — ‘aki ‘a e ‘ilo kānabinoidi na’a ne fokotu’u ki he fakalele’i ‘a Bentley.

Ko e fomuā Peace Gummies ne hoko ko ha me’angaue ‘o OilWell ‘i he ngaahi ‘ekekimeni fakapo’uli ‘oku lolotonga fakalele’i ‘e ia ‘e he fakatepe ‘o e benzo. Ke fakapapau’i ‘a e fakalele’i vave, te mā’onau fakahā ‘a e Peace Gummies ‘i he fometi vape, ‘enau ‘e Colin ‘i he taimi ni ‘oku lava ke fakapule’i ‘ene pehe mo ‘ene PTSD lahi. ‘Oku ‘ikai ko e ‘ilo tēorétikó. Na’e mo’ua ‘e Colin ‘a e me’angaue ‘oku mo’ua ‘e he kākai ‘oku ‘i RSO: fakamo’ui ‘o e fakalele’i, ‘oku ‘ikai fiemi’u ‘a e veve fakafakataute, ‘ene fakahoko ‘oku tokoni ‘a e kānabinoidi ‘e ‘ikai ke tokoni ‘a e pi.

‘Oku ngaue’i ‘e he kau fakataute ‘a mā’onau fomuā ki he ngaahi mahu’inga ‘o kupeni ‘o kau ai ‘a e tā’i ‘o e kouá, IBS, ulcerative colitis, PTSD, faka’uli ‘i he benzo, mo e insomnia. Te mā’onau fokotu’u fomuā fakafehuhu’i ki he ngaahi vegans, taihali, mo kinautolu ‘oku ‘i ai ngaahi fiema’u fakamāló — ‘okú ne fakahā ki he anga faka-Tonga, ‘oku fu’u tataki ‘a e tokoni ki he fiema’u kehekehe ‘o e kakai ‘i he kainga.

Ngaahi Fakaha’atau ‘e Toko Fitu ‘a ABC13: ‘E Fakamatala ‘a Houston

‘Oku ‘i ai ‘a e ngaahi ‘atakai ‘e toko fitu a ABC13 Houston ‘i he ta’u 2019 ki he 2023 ‘oku fakahā ‘a Colin mo OilWell. Ngaahi fepotó fēfē ‘e toko nima na’a nau fesili mai. ‘Oku ‘ikai ke ‘i ai ha kautaha fakanapisi houston ‘e taha te ne lava ‘o fetaui mo e lahi ‘o ‘eni pe fu’u.

15 ‘Epeleli 2019 — Ngaue CBD ‘oku Huhu’i: Ko mā’onau fu’u fefakatau: “Pehe ‘oku ‘ikai ke teu fakatau atu ha vai mo’oni. Pehe ‘oku ‘ikai ke teu fakatau ha toe ‘ofa, ka ‘oku ‘i ai ‘a e ngaue fakahokohoko lahi ‘i tu’a ‘oku fiema’u ke fakahā mo ke fakaseu mo ke ma’u ha fu’u lahi taha ke tokoni ki ho’o vakai’i ke fili.”

22 Māsi 2021 — Tononga Fiemu’u: Ko e fefakatau ‘o Colin: “Ko e mamahi ‘oku ‘oange ‘i he fu’u kehekehe.” Te mā’onau tokoni’i ‘a e Pina Jonathan ‘i hono fakafokotu’u ‘ene ngaue fakanapisi ‘oku hū ‘o sio, ‘oku fakahā ‘a mā’onau fu’u fu’u ngaue ki he ngaue vaha’a.

24 Mē 2021 — Delta-8 THC: Ko e fefakatau ‘o Steve Campion: “Koe’ ni’ihi ke fakahā ki he taha ke vape?” Colin: “Pehe ‘oku ‘ikai ke teu ma’u ha palopalema ‘o fakahā ke fu’u mā’u ‘a e fu’u lahi. ‘Oku ‘iai ha taha ke fiema’u fu’u lahi.” ‘Oku fakahā mo’oni ‘i he TV fakalotofonua.

20 ‘Aokosi 2021 — Fakamā ki he Veve COVID: Te mā’onau fakahā ‘a e ngaahi caviar pre-roll ‘e 1,000 (~$35,000 ‘i he me’angaue) ke fakapōpula’i ‘a e fakamā. Te mā’onau fakafekumi mo e siti ‘o Houston — ‘oku ‘ikai ha pilitiki, ko e maú ke lelei ‘a e kakai.

19 ‘Okatopa 2021 — Tononga Delta-8: ‘Oku lolotonga tatali ‘e Texas ‘a e Delta-8 ‘o ha Sākélu I ‘i he pō, na’e ‘ave ‘e Colin fakavave ‘a e me’angaue kotoa ‘i mua ‘o e fakamā, mo ne feinga ke fakamā ha kautaha kehe ‘oku ‘ikai ke mahino ‘oku ‘ave ‘a e ngaahi me’a Sākélu I. Na’e ‘oange ‘e mā’onau ha lahi ‘o e pa’anga ‘e kehekehe ke ngaue ‘o ‘aonga’.

7 ‘Okatopa 2022 — Fakamafola ‘a Biden: Na’e fakahā ‘e Colin hono hisitōria fakafoki ‘i he marijuana: “Koe’ ke fakahú ‘e ngaahi palopalema mo e fale, ngaahi tupe ma’u mo e vakai’i, ko e fiefia ‘e teu sio ke ‘ikai ke fakamā e kakai.” Ko e hisitōria fakatahatahá ‘ene ‘oku fu’u ma’u’aki ‘a e ngaahi me’a ‘i mua.

21 ‘Epeleli 2023 — 4/20 Renaissance: Colin ‘oku lolotonga kumi hemp ‘i he kamé: “Ko e taimi ‘eni ‘oku fu’u lahi ‘a e — taimi fakafou — fu’u mahu’inga ‘oku fiema’u ke fakale’olé.”

‘Oku ‘ikai ke fakatau ‘a e ngaahi fakaha’atau ‘eni — na’e fakamo’oni ‘o ‘aonga’ pe. Ki he kakai Tonga, ko e fakapapaui ‘eni ‘e he mētiā houston ‘o Amerika ‘o e fu’u fiti foki ‘o ‘ene fu’u talanoa ‘oku vakai’i ‘e he kau ‘ātita fakamongamonga.

Ngaue Fakalao: Ngaue Mo’oni, Ngaahi Tuliki Mo’oni

‘Oku ngaue fakalao mā’onau mei he 810 Richmond Avenue, Houston, TX 77006 ‘i he fakataha’anga ‘o Montrose. He ta’u 2019, ‘oku mā’onau ma’u ha pa’anga ‘e $1M ta’ú, ‘oku mau mālōlō hono lahi ‘o e mākinga ‘i Google ma’ae 5.0, pea ‘oku mau maú ha laisense ‘a Texas DSHS. Ko e ngaahi ‘ata mo e fomuā mo e paké ‘oku mau hanga ‘o ‘aho kotoa ‘i Houston ‘aki ‘a mā’onau ngaahi mele pe.

Te mā’onau ‘ave ‘a e fu’u ‘o houston mo e ‘ulu ‘o McAllen, ka ‘oku mau mālōlō ‘i he fakahā fakasimple: fakahoko ha me’angaue ‘oku ‘i ai ‘a e anga fakahokohoko, tali fakapapau, pea ‘oua ‘e fakamo’oni ko e fakanapisi ‘oku totonu ki he taha kotoa. Ko e fakamo’oni ‘eni ‘oku fiema’u keke ‘i Tonga.

Ko e Filosōfia RSO ‘o OilWell: Ngaahi Tuliki Fakamuimui ‘e Fā

Ko mā’onau fu’u fu’u fu’u kehe mei he RSO fakamuimuitaha ‘i he ngaahi fu’u fu’u fakamahu’inga’i:

1. Maau Ki He Taha Kotoa ‘I He ‘Ikai Ke Gatekeeping

‘Oku fiema’u ha kāti fakamāló. ‘E lava ‘e ha taha ta’u 21+ ke fakatau. Te mā’onau vakai’i fakavaha’apule’anga ‘i US mo fakavaha’apule’anga ki he kakai ‘oku fakapapau’i ‘ene fakalao ‘i he fonuá ni, ‘o kau ai ‘a Tonga. Na’e talitonu ‘e Simpson ‘oku fiema’u ke maau ‘a e veve ki he taha kotoa; te mā’onau fokotu’u ha me’angaue mo e fu’u fakavaha’apule’anga ‘oku fakamaluu’a.

Ki he kakai Tonga, ‘oku fakahā ‘a ‘eni:

• ‘Oku ‘ikai fiema’u ke fakahokohoko’i ha ngaahi fakamā me’alelei lolotonga ko e fakamā fakafataha ‘oku lisi
• Maau fakafa’iteliha ‘i Nuku’alofa, Vava’u, pe ‘i he fonua
• ‘Oku ‘ikai ke gatekeeping ‘e he ngaahi fakamaau — te mā’onau talitonú keke ‘o fai ‘a e ngaahi fili fakamahino’i mo ho’okau kainga

2. Veve ‘Oku Pule’i ‘E He Taha Kuo Puke

Ko e THCa ‘oku fakatau ‘i hono fo’i, ‘oku ‘ikai-psychotropic. ‘Oku ma’u pule ke fakafoki ‘i he taha ‘oku ‘ikai psychoactive pe ke fakasoa’i ki delta-9 THC ki he veve psychoactive lahi. Na’e talitonu ‘e Simpson ‘oku fiema’u ke fakapule’i ‘e he taha ‘ene veve; te mā’onau fokotu’u ha me’angaue ‘oku fakapule’i ‘a e pule ‘eni ki ho’o nima ‘aki ‘a e kemisitulii, ‘ikai ko e ngaue.

Ngaahi fu’u ngaue ‘e tolu mei ha me’angaue ‘e taha:

• Fakamā, ‘ikai veveli: ‘E mau ‘a e 1,500mg THCa kotoa ‘oku ‘ikai-psychotropic — fu’u lahi ki he ngaue ‘aho lolotonga ‘i Tonga ‘oku fu’u veveli ‘okú ke fiema’u ke ngaue, ta’eteu, pe tokoni’i he fāmili ‘ikai ke fu’u lahi
• Fakasoa’i kakato, decarboxylation ‘i api: Ko e veveli ‘i he 260°F (125°C) ‘i he minute ‘e 45-60 ‘oku faka’uli ‘a e 1,500mg THCa → ~1,315mg delta-9 THC. Fakafufu mo e 90mg delta-9 THC = ~1,405mg fakakatoa. ‘Oku lava ‘e ia ‘i he fu’u lahi tatau mo e lahi ‘oku fakafoki ‘i he RSO ‘oku fā’ú, 100% fakalao
• Vape, auto-decarboxylation: Ko mā’onau vape cartridge ‘oku faka’uli vave ‘a e THCa ‘i he 400-450°F, ‘oku foaki ‘a e fakalele’i vave taha ki he ngaahi ongo mamahi

Ko e faka’uli: 1mg THCa = 0.877mg delta-9 THC ‘i he mui ‘o e decarboxylation (fakapapau’i ‘a e momo’i ‘o e CO₂). ‘Oku faka’uhingá ha fakatau ‘e taha ‘oku tokoni ki he ngaahi fiema’u kehekehe — ‘oku mahu’inga lahi ki he kainga Tonga ‘oku pule’i ‘ene pū’anga pa’anga.

3. Ngaahi Fomuā Fakafepaki

Fakapapau’i ‘e mā’onau ‘a e ngaahi fomuā fakakatoa fakafepaki — kotoa e kānabinoidi, kotoa e miligalamá, kotoa e pasentít. ‘Okapau ‘oku ‘ikai ke teke lava (taimi $129.99 ki he ‘ela heke, $49.99 ki he vape cartridge), ‘e lava ‘e keke ‘o sio ki he mea ‘oku ‘i he fomuá, tu’u ki he kānabinoidi ‘i ha taha, mo hanga ‘a ho’o vā.

Ko e ‘ulungāanga ‘eni ‘oku fakatau’ata ‘a e fu’u tataki ‘a Simpson. Na’e fakafoki ‘e ia ‘a e ‘ela pe mole mo fakafunduhí ha kakai. ‘Oku ‘ikai ke ne pātenita’i hono fu’u tataki. Te mā’onau fakalele’i ‘aki ‘i he ngaue fakanapisi fakafou: fakatau ha me’angaue ‘oku fakasiosio’i, vakai’i fakafakataute, fakatonutonu’i ‘e ngaue ‘ikai ha fili, pe fakahā fakafepaki ‘a e fomuá fakakatoa ki he kakai ‘oku fiema’u ke hanga ‘e ia ‘e he taha.

Ki he kakai Tonga ‘oku hanga ‘a e me’angaue ‘io, mo e kau fakataute ‘oku tauhi ‘a e ‘akau, ko e fakahā fakafepaki ‘eni ‘oku faka’apa’apa’i ho’o ‘ilo mo ho’o pule’i. ‘E lava ‘e keke toe fakaliliu, fakapōpula’i, mo fefakatau’akí ‘i ho’o kainga ‘i he fiema’u faka’ekitimí.

4. Tokoni’i ‘e Fakamo’oni, ‘Ikái Ke Fakaleveleva ‘a e Fakamo’oni

Ko e tohi fakakatoa ‘eni ‘oku fakahā ‘a mā’onau fu’u talitonu ki he ngaue fakamahino’i ‘o e me’a ‘oku fakamo’oni. Na’e ngaue ‘e Simpson ‘okú ne maú ha fakamatala fakakolosi; te mā’onau maú ‘eni pea ‘oku mau ngaue’i ‘aki ke fakavahevahe’i ‘i he me’a ‘oku fu’u tokoni’i, ‘oku lolotonga tupu, mo ‘oku lolotonga fakaleveleva. Kotoa e tala ‘oku mau tala ‘oku fakapupula’i ‘i he cite fakakolosi ‘oku mahu’inga’i [1]-[29].

Ko e Saiēnisi: Fakamahino’i ‘a e Kānabinoidi mo e Tēpeni

Hiehia ‘o e Fakamo’oni: Ko e Fu’u Fu’u Te Máu ‘O Fakavakai’i

‘Oku fakamahu’inga’i ‘e mā’onau ngaahi pule’anga ‘i he fu’u fakafekiki ‘eni: fakamo’oni ‘i he tagata fakamua, fakamatala fakakolosi, mo e Ngaahi Tu’utu’uni ‘o e Ngaahi Fale, ‘ikai ko e mata’itohi fakamaté mo fakahokohoko.

Ki he kakai Tonga, ko e fu’u fu’u ‘eni ‘oku tokoni ke fakaha’apulé ‘i he fu’u lahi ‘o e fakamatala fakanapisi ‘i he ‘initanéte — lahi ‘e he US pe Kanatá ‘oku ‘ikai ke fetau’aki mo ho’o vaha’a. Te mā’onau fakapupula’i kotoa e tala ‘i he saiēnisi mo’oni, ‘ikai ko e fakatau.

Fomuā Kānabinoidi: Ko e Me’a ‘E Ngaue ‘E Kina Kinautolu

CBD (Cannabidiol) — 4,500mg ‘i he mā’onau formula heke

Ko e fakamo’oni lahi taha ‘i he’etau vaha’a ‘i he tagata [1]-[6].

Ko e me’a ‘oku fu’u tokoni’i taha: CBD ‘oku fakasiosio’i ki he ngaahi veve fefunga (vahe ‘e Epidiolex ‘e FDA) [1][2].

Fakamalohi: Ko e fakamatala fakafakataute fakama’u 2024 ‘oku fakahū’i 316 kakai ‘i he ta’u 8 na’e fakahā ‘a e fu’u lahi ‘oku ‘i ai ‘a e efekí fakamalohi, ka na’e fakama’u ‘e he kau ‘ātita ‘oku lahi fau ha kakai ke fakahoko ha ngaue fakakolosi [3]. Ki he kakai Tonga ‘oku fu’u fakamalohi ‘i he ngaahi pē ‘i he ngaue mo e kakai, ‘oku fakahā ‘e ‘eni ‘e lava ke tokoni ‘a e CBD, ka ‘oku ‘ikai ko ha fakafu’uti ‘oku fakapapau’i.

Mamahi: Ko e fakamatala fakafakataute fakama’u 2024 na’e fakahā ‘a e literetea ‘oku toe tu’utu’uni ka ‘oku ‘iai ‘a e ngaue ‘oku kehekehe, ‘oku ‘iai e ngaahi veve ‘oku ‘oange ‘e he kaliti ‘o e taiki ‘e fakasi’isi’i e fakapapau’i ‘i he ngaahi tala fakamamahi [4]. ‘I he Tonga ‘oku lisi ‘a e fakamā ‘o e momoa ‘oku ‘iai e CBD ko ha fu’u, ka ‘oku fiema’u e fakamo’oni fakaloto’i.

Mohe: Ko e fakamatala fakafakataute fakama’u 2023 insomnia na’e fakahā ‘a e literetea ‘oku ‘iai e ngaahi fu’u fu’u tu’utu’uni, ‘oku lahi e ngaue ‘oku fakatau ‘i he ngaahi me’angaue fakakatoa [5]. ‘Okapau ‘oku ke ‘i Ha’apai ‘oku fu’u fu’u momoa ‘i he mamahi fakakatoa, ‘e lava ke tokoni ‘a e CBD, ka ‘oku ‘ikai ko ha veve ‘oku fakapapau’i.

Fakamamā’i: Ko e fakamatala fakafakataute fakama’u 2023 na’e fu’u lahi ‘e he ngaahi signal ‘o e ngaue ‘o e fu’u lahi ‘o e anisimi ‘a e toto (ALT/AST), mo e ‘ikai ‘o e si’isi’i ‘o e vai ‘i he fu’u [6]. Na’e fakahā foki ‘e NCCIH ‘e diarrhea, ‘oku fu’u fu’u mohe, fiema’u ‘o kai, ongo ‘o loto, mo e ngaahi fefekí mo e ngaahi veve [1]. ‘Okapau ‘oku ke ‘i ai ha veve kehe (fu’u lahi ‘i he kakai Tonga ‘oku lolotonga lolotonga) fesili’i fakataute ‘uluaki.

CBG (Cannabigerol) — 3,000mg ‘i he mā’onau formula

Fakafakataute ‘i he fakamatala fakakolosi [7][8].

Ko e CBG ko e me’a ‘uluaki ‘o e ngaahi kānabinoidi lahi. ‘Oku fetau’aki mo e ngaahi fokotu’u ‘o e kānabinoidi, alpha-2 adrenoceptors, mo e 5-HT1A signaling, ‘oku fu’u mahu’inga ka ‘oku ‘ikai fakatonutonuí [7]. ‘Oku fakahā ‘i he ngaahi fakamatala ‘e ‘ lava ke tokoni ‘i he ngaahi mātu’a neolojik, inflammatory bowel disease, mo e ngaue fakalelei lelei, ka ‘oku fakafakataute pe ‘i he [7][8].

Ki he kakai Tonga: Ko e CBG ‘oku fakafakataute fakalao ‘okú ne ‘oku ‘ikai ke fakakamata’i, ‘ona ‘oku lahi ‘e he ngaahi tala ‘oku ‘i lalo ‘o e saiēnisi. Te mā’onau fakafufu ai ‘ene fu’u tataki ‘o Bentley ‘i hono fakatangata ‘o e ‘atamaiá, ‘ikai ‘okú ne fakamo’oni ‘a e taiki ‘i he tagata.

Delta-8 THC — 6,000mg ‘i he mā’onau formula

Fakatonutonu fakafakataute, psychoactive, ‘oku ‘ikai fu’u fakamatala’i taha ‘i he delta-9 THC [9]-[11].

Ko e fakamatala fakafakataute fakama’u 2022 na’e fakahā ‘a e delta-8 THC mo e delta-9 THC ‘oku ‘i ai e ngaue fakafakataute tatau. Ko e delta-8 ko ha partial CB1 agonist ‘oku ‘i ai e cannabimimetic activity, ka ‘e fakahā ‘e ia ‘oku si’isi’i ange ‘i he delta-9, mā’u pē ‘i he fu’u lahi ‘e si’isi’i CB1 [9].

Ko e fakamatala fakafakataute fakama’u 2023 na’e fakahā ‘a e literetea ‘o e delta-8 ‘oku fakahū’i ‘e ngaahi taiki ‘i elilí, kemisitulí ‘o e me’angaue, mo e palopalema fakama’a kakai ‘e ‘ ke fu’u lahi taiki ‘i he tagata. Na’e fakamāhu ‘e ia ‘e palopalema fakapule’anga [10]. ‘Oku fakahā ‘i he fakamatala ‘o e kemisituli ‘a e Delta-8 ‘oku fakahokohoko ‘i he fu’u lahi mo fu’u totonu ange ‘i he me’angaue lahi [11].

Ki he kakai Tonga: Ko e Delta-8 THC ‘oku fiema’u fakatonutonu’i ‘o ha psychoactive THC analogue ‘oku ‘i ai e ngaue fakakatoa ka ‘oku ‘ikai ke fu’u fakamatala’i ‘ene fakatonutonu. ‘Okapau ‘oku ke fakapaapau’i ‘i he fu’u (fu’u lahi ‘i he kainga fakalotofonua ‘i Tonga), kamata ‘i he formula THCa fakamā ‘e alu ‘a e decarboxylation ke fu’u ‘ilo’i ho’o tali.

THCa (Tetrahydrocannabinolic Acid) — 1,500mg ‘i he mā’onau formula

Fakamahu’inga ‘i he kemisituli mo fu’u fu’u, ka lahi ‘i he fakamo’oni fakafakamā [12].

Ko e THCa ko e me’a ‘uluaki ‘o e THC mo ‘e lava ‘o fōki ki he lahi ‘o e THC ‘i he sipinga ‘oku ‘ikai ke fakamaú. ‘Oku fakasoa’i ki he THC ‘i he veveli pea ‘e lava ‘o liliu ‘i he fakatonutonu [12]. Ko e THCa ‘i he’ene taká ‘oku fu’u toto ‘o ‘ikai ha efekí psychoactive — ka pehe ‘oku ‘i he fo’i taká pea ‘oku ‘ikai decarboxylated [12].

‘Oku fakahā ‘i he elili mo lelilí ‘oku ia ‘e fatongi fakasi’isi’i ‘o e kovi, fakatonutonu’i ‘a e fakamā, fakapaopao’i ‘o e ‘atamaiá, mo e fakasi’isi’i ‘a e fefunga, ka ‘oku ‘ikai ko e hokó ‘i he tagata mo’oni [12].

Ki he kakai Tonga: Ko e loto ‘o e veve ‘oku fakapule’i ‘e he taha. Ngaue’i ‘a e ‘ela fakamā (fu’u veveli) ki he fakalele’i fakamā ‘i he ‘aho. Decarboxylate ki he fakalele’i ‘i he po pe ‘oku fu’u mamahi. Ko e fili ‘eni ho’o, ‘ikai ko e me’a ‘oku fu’u fakapupula’i ‘e mā’onau.

Delta-9 THC — 90mg ‘i he pepa kotoa (3mg/mL)

Ko e fakamo’oni lahi taha ‘o e kānabinoidi psychoactive, ka ‘oku ‘i ai e palopalema lahi taha ‘o e fakamamā’i [1][13]-[15].

Ko e NCCIH ‘oku fakahū’i ‘e THC ‘oku tokoni ‘i he fakatepe ‘o e kemotērapi, mamafi ‘o e HIV/AIDS, mo e MS/mamahi [1]. Ko e fakamatala fakafakataute fakama’u 2022 na’e fakahā ‘a e me’angaue THC lahi mo ‘e tokoni fakafu’u mamahi ka ‘oku fu’u lahi ‘i he fu’u, tu’utu’uní, fakatepe, mo e tu’utu’uni ‘o fakahoko ‘e he kakai [13].

Ko e pharmacokinetics: ‘Oku hokó ‘a e THC ‘oku huhu ‘i he sekoni-minute, fu’u ‘i he minute ‘e 15-30, mo fu’u ‘i he houa; ‘Oku fu’u lahi ‘a e THC ‘oku fakateu [14].

Riski fakapoto o e ‘atamaiá: Ko e fakamatala fakafakataute fakama’u 2025 na’e fakahā ‘a e fu’u lahi ‘oku lelei ‘oku ‘i ai e fu’u lahi ‘i he psychosis/schizophrenia mo e faka’uli ‘i he fakanapisi, mo e ongo fakafakamamahi ‘i he anxiety/depression ‘i he ngaahi feitu’u ‘oku ‘ikai fakamā [15]. ‘Oku mahu’inga lahi ‘eni ki he kainga Tonga ‘oku lahi ‘a e stigma ‘o e ‘atamaiá — te mā’onau fiema’u ke fakahoa fakamo’oni ki he palopalema.

Fakatonutonu fakakatoa: Anxiety/panic ‘i he veve lahi, tachycardia, faka’uli ‘o e toto, fu’u fiema’u ‘o faka’apa’apa’i, fakafoki mo e pehe ‘oku fu’u, palopalema ‘o e fu’u, mo e fu’u mātu’a [1][14][15].

Fu’u tataki ‘a mā’onau: Te mā’onau fakafufu ai ‘e 90mg delta-9 THC fakakatoa — lahi fuka lalo ‘i he 600-900mg/’aho ‘a Simpson — lolotonga fakahā ‘a e THCa ‘oku fu’u fakasoa’i ‘e he taha ‘oku fiema’u fu’u. ‘Oku fakapapau’i ‘eni ‘a e fu’u ke tokoni’i mo e fakatonutonu.

CBN (Cannabinol) — 750mg ‘i he mā’onau formula

Fakamo’oni fu’u lahi ‘i he tagata; tala fakavaha’apule’anga ‘ū mua ‘i he fakamo’oni [12][16][17].

‘Oku fakatau fakavaha’apule’anga ‘a e CBN ki he momo, ka ‘oku lahi fuka lalo ‘i he tala fakavaha’apule’anga. Ko e fakamatala fakafakataute fakama’u 2021 na’e vakai’i e 99 fakamatala ‘o e tagata mo ne fakahā ‘oku ‘ikai ke vakai’i ha taiki fakafakataute ‘oku vakai’i polysomnography ‘e lava ke fakapapau’i tala fakamamā lahi [16]. Ko e fakamatala fakafakataute fakama’u 2024 na’e fakahā ‘oku ‘iai fu’u lahi ‘oku ‘ikai fetau’aki mo e fu’u lahi ‘o e tala fakavaha’apule’anga [17].

Ki he kakai Tonga ‘oku fu’u fu’u momoa: Te mā’onau fakafufu ‘a e CBN ‘i he fu’u tataki ‘o ‘ene fakamoihá mo e fakamatala fakamuimuitaha, ka ‘e ‘ikai fakahoa fakaleveleva ‘a e fakamo’oni. ‘I he 750mg he pepa, ko e mL ‘e taha ‘oku 25mg CBN — lahi ‘i he 20mg ‘oku fetau’aki mo e fakasi’isi’i ‘o e fakamamā ‘i he literetea fakama’u 2024, ka ‘oku ‘ikai ko ha fakafu’uti ‘oku fakapapau’i.

CBC (Cannabichromene) — 750mg ‘i he mā’onau formula

Fu’u faka’uli, fu’u mahu’inga, fu’u lahi ‘i he fakafakataute [18][19].

Ko e fakamatala fakafakataute fakama’u 2024 ‘oku fakahā ‘a e CBC ‘oku ‘i ai e ngaue fakakatoa kehe mo ‘oku fakamahu’inga taha ‘i he mamahi, fakalelei ‘o lelei, mo e fakasi’isi’i ‘o e fefunga [18]. ‘Oku fakahā ‘i he literetea talu ‘oku fakasi’isi’i ‘o e kovi, fakasi’isi’i ‘o e gut hypermobility, fakamalohi fakasi’isi’i ‘i lelilí, mo e faka’uli ‘oku faka’apa’apa’i [19].

Fakamā’u fakatonutonu: Ko e fakamatala fakama’u 2024 ‘oku fakahū’i fakapāpau’i ‘oku fakatau ‘a e ngaahi me’angaue CBC ‘i he faka’ilonga ‘e kehe ‘e ‘i ai e fakamo’oni fakakolosi ‘e puipui’i ‘a e efekí mo e fakatonutonu [18].

Fu’u fakamata: Ko e CBC ‘oku mahu’inga ‘i he saiēnisi ka ‘oku ‘ikai ke fu’u fakahokohoko. Te mā’onau fakafufu ai ‘i he fu’u tataki ‘o Bentley ‘i hono fakatangata ‘o e ‘atamaiá, ‘ikai ‘okú ne fakamo’oni ‘a e taiki ‘i he tagata.

Fomuā Tēpeni: Ko e Fu’u Fakahā Mo’oni

Ko e ngaahi tala ‘o e tēpeni ‘oku fiema’u fakatonutonu’i taha ‘i he tala ‘o e kānabinoidi. Lahi ‘o e literetea ‘oku ‘i ai mei he ngaahi me’a ‘oku ‘ikai tatau, ‘eila fakanatulá, sipinga ‘oku ‘ikai ko e fakanapisi, pe fu’u elilí. ‘Oku lisi ‘a e fakamo’oni fakapapau’i ‘o e efekí fakamamā ‘o e entourage ‘i he tagata [20][29].

Ko mā’onau formula na’e fakafufu ‘ 5% tēpeni ‘oku lolotonga ola ‘i he tēpeni ‘e toko fitu ‘oku fakamahu’inga’i:

Limonene (sītasi-pala)

Ko e tēpeni ‘oku ‘i ai e fakapaopao’i ‘o e kovi, fakasi’isi’i ‘o e kovi, mo e fakapaopao’i ‘o e toto — lahi ‘i he literetea ‘oku ‘ikai elilí pe ‘oku ‘ikai fakanapisi [21]. Fakamā’u fakatonutonu: ko e ngaahi me’a ‘o e limonene ‘oku ‘i ai ‘a e fu’u lahi ‘o e mumui [22].

Myrcene

‘Oku fakahā ‘e fakamalohi, fakapaopao’i ‘o e kovi, fakasi’isi’i ‘o e kovi, mo e fakamalohi fakasi’isi’i ‘i he fu’u fakafakataute, ka lahi ‘e he taiki ‘i he tagata [23]. Ko e tala ‘oku fu’u lahi ‘oku fakahā ‘a e myrcene ne fakafu’uti mo e fu’u ‘i ai ‘o e “couch-lock” ‘oku lahi ‘i he fakamo’oni ‘i he fu’u.

Beta-Caryophyllene (pepa/saisi)

Ko e tēpeni ‘oku fu’u mahu’inga ‘i he kemisituli — selective CB2 receptor agonist, ‘oku ne fu’u mahu’inga ‘i he pharmacology ‘o e fu’u lahi [24]. ‘Oku fakahā ‘e fakasi’isi’i ‘o e kovi, fakatonutonu’i ‘a e fakamā, mo e fakapaopao’i ‘o e ‘atamaiá, ka ‘oku lahi ‘a e taiki ‘i he tagata [24].

Pinene (foréti-vāvā)

‘Oku fu’u faka’uli ‘i he fakapaopao’i ‘o e kovi, fakasi’isi’i ‘o e kovi, mo e fakapaopao’i ‘o e ‘atamaiá, ka ‘oku ‘i ai e ngaahi taiki fakafakataute ‘oku lahi [25]. Ko e tala ‘oku fu’u lahi ‘oku tokoni ‘i he fakamanatu pe mo e fakasi’isi’i ‘o e fu’u ‘o e THC ‘oku tala pe, ‘ikai ko e fakamo’oni fakapapau’i.

Linalool (vai, ‘uhinga)

‘Oku fakahā ‘i he ngaahi fakamatala ‘oku tokoni ‘i he pē, loto, mo e ‘atamaiá, ka ‘oku lahi ‘i he fu’u fakafakataute [25][26]. Ko e linalool ‘oku ‘i ai e ngaahi fu’u lahi ‘o e mumui [22].

Humulene (fonua, vao)

Fu’u fakafakataute ‘oku mahu’inga ‘i he liliu, ‘oku ‘i ai e ngaahi taiki ‘i lelilí ‘oku fakahā ‘e cannabimimetic properties via CB1 mo e founga adenosine A2a [27], ka ‘oku ‘ikai ke fu’u fakahokohoko.

Terpinolene (paina, fua, pala)

Ko e tēpeni ‘oku fu’u lisi ‘i he fakamatala fakafakataute. Ko e literetea ‘oku lahi ‘i he fu’u in silico, in vitro, mo e taiki ‘i lelilí [28].

Ki he kakai Tonga: Ko e ngaahi tēpeni ‘eni ‘oku fu’u fu’u fakahā mo’oni — ko e ongo sītasi ‘o e limonene, ko e ongo foréti ‘o e pinene ‘oku lava ke fakamanatu atu koe ki he foréti pine ‘i ‘Eua, ko e fu’u kaukaua ‘o e caryophyllene. ‘O liliu ‘e he tala ‘o e veve fakapaopau’i, ka ‘oku fakahā ‘e ‘eni mo e ongo mo e fu’u tokoni ki he fu’u ‘atā ‘o e veve.

Ngaahi Tā’efakamā Mo e Fakamahino’i: Ko e Fu’u Fakahō Atú Ki He Koe

‘Oku fiema’u ke fakahō atu ‘a mā’onau ki he kainga Tonga ‘a e me’a ‘oku tevolo ‘e mā’onau ‘ilo pe ‘ikai:

1. ‘Oku faka’uli ‘a e fakamo’oni. Ko e CBD mo e delta-9 THC ‘oku ‘i ai e fakamo’oni lahi ‘i he tagata; delta-8, THCa, CBG, CBN, CBC, mo e tēpeni ‘oku fakahū’i ‘i he fakamatala, fakafakataute, mo e pharmacology [1]-[29].

2. ‘Oku ‘ikai fetau’aki e fakamatala. Ko e me’a lolotonga fakahā ‘oku ‘i ai ‘oku ‘i he me’angaue kehe ‘e fu’u fu’u.

3. Ko e ngaahi kānabinoidi si’isi’i ‘oku fakafakataute fakalao okú ne ‘oku ‘iai e fu’u lahi o ngaue, ‘o fu’u lahi ‘a e tala ‘i lalo ‘o e saiēnisi. Te mā’onau tā’efakamā ‘eni.

4. Ko e kaliti ‘o e me’angaue ‘oku fakahā ‘o fakatau mo e me’a ‘oku mahu’inga. Ko e ngaue ‘oku ‘ikai fakamahu’inga’i, fakatā’efakamā, byproducts ‘o e fu’u ngaue, mo e vahevahe ‘o e veve ‘oku fakaha’avá ‘i he saiti ‘oku hokó [1][10][11][14]. Ko mā’onau fakavakai’i fakakolosi kotoa e ‘eni.

5. Ko e kemisituli ‘o e THCa ‘oku liliu ‘i he fakatonutonu mo e veveli. Ko e me’angaue ‘oku ke kamata mo ia ‘e ‘ikai ke ‘oange ia ‘i he me’a ‘oku ke lava ‘i he mui — ‘oku mahu’inga ‘i he Tonga ‘oku fu’u veveli ‘o e ‘ao ‘oku liliu e ngaahi fu’u fakatonutonu [12].

Ngaahi Tā’efakamā Ma’u

• Tā’efakamā: Ko e CBN ko ha kānabinoidi ‘oku fakamo’oni fakapapau’i ki he momo. Mo’oni: ‘Oku lahi fuka lalo e fakamo’oni ‘o e CBN ki he momo [16][17].
• Tā’efakamā: Ko e myrcene ‘oku fakafu’uti mo ke fu’u mohe/”couch-lock”. Mo’oni: ‘Oku lahi ‘e fu’u fakafakataute e fakamo’oni ‘i he tagata [23].
• Tā’efakamā: Ko e tēpeni ‘oku fakamo’oni fakapapau’i ‘o e efekí entourage. Mo’oni: ‘Oku lahi fuka lalo e fakamo’oni fakapapau’i ‘i he tagata [20][29].
• Tā’efakamā: Ko e THCa ‘oku ‘oange ‘oku ‘ikai psychoactive. Mo’oni: Ko e veveli ‘e fakasoa’i e THCa ki he THC [12].
• Tā’efakamā: Ko e Delta-8 THC ‘oku malu’i ‘a tanu ‘oku ha hemp-derived. Mo’oni: Ko e Delta-8 ‘oku psychoactive ‘oku ‘iai e fu’u lahi ‘oku fakatonutonui [9]-[11].

Ko e Fomuā RSO ‘a Mā’onau: ‘Oku Fakahū Fakafepaki

RSO ‘Ela Heke — $129.99

Kānabinoidi	Lahi	Fu’u Tā
CBD	4,500mg	Kānabinoidi fakamuimui, fakamalohi, fakasi’isi’i ‘o e kovi
CBG	3,000mg	Fakapaopao’i ‘o e ‘atamaiá, tokoni fakamuimui ki he GI
Delta-8 THC	6,000mg	Fakatonutonu’i o e mamahi, fakatepe, fu’u psychoactive
THCa	1,500mg	Veve ‘oku fakapule’i ‘e he taha, fu’u fakasi’isi’i ‘o e kovi
Delta-9 THC	90mg	THC fakamuimui, fakamaluu fakalao
CBN	750mg	Tokoni ki he momo (fakakataki)
CBC	750mg	Fakahokohoko ‘o e ‘atamaiá, fu’u tokoni’i ‘a e CBG
Fakakatoa	16,590mg	553mg he mL

Ngaahi me’a kehe:

• Tēpeni Lolotonga Ola: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Kālia: MCT oil ‘oku ‘ikai ke toe faka’iloa’i
• Veve: Pipete fakamātu’a ‘i he 0.1mL
• ‘A’ahi: Minute 15-45 (fu’u heke)
• Fu’u: Houa 1-2
• Mamafa: Houa 4-6
• Bioavailability: 13-19% (fu’u lalo ‘i he fu’u ‘o e toto)
• Veve he pepa: Tokolahi he 40-60 ‘i he lahi ‘o e veve

Fu’u tā ki he Tonga: Kamata ‘i he 0.25-0.5mL (138-277mg kānabinoidi fakakatoa) ke fakavakai’i e efekí ‘i mua ‘o toe liliu. ‘Oku fu’u lahi ‘a ‘eni ‘i he fakatonutonu ‘o Simpson “fo’i mehiki”.

RSO Vape Cartridge — $49.99

Kānabinoidi	Pasentí	Fu’u Tā
CBD	30%	Fakamuimui, fakamalohi
CBG	20%	Fakapaopao’i ‘o e ‘atamaiá
Delta-8 THC	15%	Mamahi, psychoactive
THCa	10%	Fu’u fakasoa’i ki he THC ‘i he vape
CBN	10%	Tokoni ki he momo
CBC	10%	Fakahokohoko ‘o e ‘atamaiá
Tēpeni Lolotonga Ola	5%+	Fakahā, tokoni entourage

Ngaahi me’a kehe:

• Fometi: 1-gram 510-thread cartridge (batāli fakalotofonua)
• ‘A’ahi: Minute 1-2 (fu’u vave taha)
• Fu’u: Minute 10-15
• Mamafa: Houa 2-4
• Bioavailability: 10-35% (fakatefito ‘i he fu’u ‘o e fu’u)
• Auto-decarboxylation: Ko e vaping ‘i he 400-450°F ‘e faka’uli vave ‘a e THCa ki he delta-9 THC

Ki he kakai Tonga: Ko e vape ‘oku fu’u vave fakalele’i ki he mamahi fakapo. Ka ‘oku te mahino ‘oku ‘iai e ngaahi anga faka-Tonga ‘oku fakafekiki mo e fu’u ngaue ‘oku fu’u. Ko e ‘ela heke ‘e lava ‘e ia ke fu’u tui ‘i he fu’u ola ‘aho kotoa.

Me’angaue: He Taimi ‘Oku Fiema’u ‘E Kina Kinautolu: Ha Fu’u Tokoni Ki He Mo’ui ‘o Tonga

Fu’u Fiema’u	Me’angaue ‘E Fiema’u	Fakamahino’i Ki He Vaha’a ‘o Tonga
Fakalele’i vave (mamahi fakapo, fakatepe, palopalema)	Vape	Fu’u vave ‘i he minute 1-2 ‘oku mahu’inga ‘okú ne hoko mamahi vave
Fakalele’i fu’u (mamahi fakakatoa, tokoni ‘aho kotoa)	‘Ela heke	Mamafa houa 4-6 ‘oku fetau’aki mo e ngaue ‘aho pe mohe ‘ao
Bioavailability lahi taha	‘Ela heke	13-19% ‘oku fu’u fu’u mei he mL
Maau fakatau/fakamā	Vape	Fu’u lata pe ke fakatau ‘i he vaha’a ‘o e ngaahi motu pe ki he kolo
Pule’i veve fakatonutonu	‘Ela heke	Pipete fakamātu’a ‘oku tokoni ke fakatonutonu’i ‘aupito
Ngaue ‘aho ‘oku ‘ikai psychoactive	‘Ela heke (fakamā)	THCa ‘e mau mo ia ‘ikai fakasoa’i — ngaue, ta’eteu, tokoni ki he fāmili ‘ikai ke fu’u
Ngaue po ‘oku psychoactive	‘Ela heke (fakasoa’i) pe vape	Fakasoa’i ki he ongo mamahi lahi pe tokoni ki he momo

Tokoni Fakafekiki Ki He Fiema’u ‘Onga ‘O Tonga

Fakamā’u fakatonutonu: Ko e ngaahi fakamahino’i ‘eni ‘oku fakahā ‘e he me’a fakahū’i ki he kānabinoidi. ‘Oku ‘ikai ko ha fakafekiki fakataute, ‘ikai ko e FDA-fakamo’oni’i, ‘ikai ko e fu’u fu’u fakafekiki fakataute fakamā. ‘Oku ‘ikai vakai’i ‘e he FDA ‘a e me’angaue ‘eni. ‘Oi tali ‘e he fakataute fakalao ‘i mua ‘o ke ngaue’i ngaahi me’angaue kānabinoidi, fu’u lahi ‘okú ke veve, fiema’u veve kehe, ‘oku ke fu’u pe tokoni’i, pe ‘okú ke fiema’u fakamāló. ‘Ouá ngaue’i ngaahi me’a fakato’onga pe ngaue ‘i he fu’u ‘o e kānabinoidi psychoactive.

Tokoni Ki He Fakatepe ‘O E Kemotērapi Mo E Fiema’u Kai

Fu’u tā:

• Ki mu’a ‘o e kemotērapi: 0.5-1.0mL heke ‘i he taimi houa 1 ‘i mua ‘o e tala
• Fakatepe fakapo: Vape 2-3 puffs ki he fakalele’i vave (minute 1-2)
• Ki mui ‘o e kemotērapi: 0.5mL heke ‘i he houa 6 ‘okú ke fiema’u
• Tokoni ki he momo: 1.0-2.0mL heke ‘i he po (tokoni 25-50mg CBN)

Fakamo’oni: Ko e efekí antiemetic ‘o delta-8 THC [9], delta-9 THC ki he fakatepe [1][13], CBD ki he fakamalohi [3]

Fu’u tā ki he vaha’a ‘o Tonga: ‘Oku fiema’u fakaloloa ‘a e fakamā ‘o e kāniva ‘i Nu’usila pe ‘Aositēlelia. ‘E lava ‘e mā’onau vakai’i fakavaha’apule’anga ki he ke na’a ke lolotonga tokoni’i ai. Ko e fu’u fakamā ‘oku ‘ikai psychoactive ‘oku lava ke ngaue’i ‘i he ‘aho ‘oku ‘ikai ke fakafu’uti mo ho’okau kainga.

Mamahi Fakakatoa (Arthritis, Neuropathy, Fibromyalgia)

Fu’u tā:

• ‘Aho: 0.3-0.5mL heke fakamā — fakasi’isi’i ‘o e kovi ‘ikai ke fu’u
• Po: 0.5-1.0mL heke fakasoa’i — fu’u mamahi pea fakafufu mo e CBN ki he momo
• Mamahi fakapo: Vape ‘okú ke fiema’u

Fakamo’oni: Fakamatala mamahi ‘o e CBD [4], delta-9 THC [13], beta-caryophyllene CB2 agonism [24], COX-2 inhibition ‘o e THCa [12]

Fu’u tā ki he vaha’a ‘o Tonga: ‘Oku lahi ‘a e mamahi fakakatoa ‘i he ngaahi kainga ngāue mo e fika. Ko e lisi ‘o e fakamā ‘o e momoa ‘oku fakahā ‘a e fu’u fakapule’i ‘e ho’o taha. Ko mā’onau pipete fakamātu’a ‘oku tokoni ke fakatonutonu’i ‘aupito.

Ngaahi Palopalema Mohe Mo E Insomnia

Fu’u tā:

• Ki he momo: 1.0-2.0mL heke
• ‘I he 2.0mL: ‘Oku foaki ‘e 50mg CBN (lahi ‘i he literetea fakama’u 2024)
• ‘I he 1.0mL: ‘Oku foaki ‘e 25mg CBN (lahi ‘i he 20mg ‘oku fetau’aki mo e fakasi’isi’i ‘o e fakamamá)

Fakamo’oni: Fakamatala momo ‘o e CBN [16][17], literetea fakanapisi mo e momo

Fu’u tā ki he vaha’a ‘o Tonga: ‘Oku vā vā ‘a e fakamamá mei he mamahi, pē, pe ngaue shifí (fu’u lahi ‘i he tourism pe fika). Ko e mamafa houa 4-6 ‘o e ‘ela heke ‘oku tokoni ki he momo ‘aho kotoa. Ka ‘oku te mahino ‘oku lahi fuka lalo e fakamo’oni ‘o e CBN — te mā’onau fakafufu ai ‘i he fu’u tataki, ‘ikai oku fakamo’oni fakapapau’i.

Fakamalohi, Pē, Mo PTSD

Fu’u tā:

• Fakalele’i fakamā ‘i he ‘aho: 0.3mL heke fakamā — CBD mo e CBG ‘oku tokoni ‘i he fu’u fakamalohi ‘ikai ke fu’u
• Po: 1.0mL heke — fu’u fu’u fakakatoa fakafufu mo e CBN ki he fu’u momo

Fakamo’oni: Fakamatala fakamalohi ‘o e CBD [3], pharmacology ‘o e CBG [7][8], efekí entourage ‘o e limonene [20]

Fu’u tā ki he vaha’a ‘o Tonga: ‘Oku lahi ‘a e stigma ‘o e ‘atamaiá ‘i he kainga Pasifiki. Ko mā’onau ‘ela heke fakamā ‘oku tokoni ke ngaue’i ‘i he taimi fakatau. Ko e fu’u fakamā ‘oku ‘ikai psychoactive ‘oku lava ke fakapule’i ‘i he ngaue mo e fakapē ‘i he siasí ‘ikai ke fu’u.

Fu’u Fakalao: Tononga Farm Bill Mo Maau Fakavaha’apule’anga

Ko e Fu’u Fakalao ‘O E THCa

Ko e Farm Bill 2018 ne fakalao’i ‘a e ngaahi me’angaue hemp-derived ‘i US ‘oku ‘i ai ‘a e fu’u laho ‘o 0.3% delta-9 THC. Ko mā’onau ‘ela heke ‘oku ‘i ai pe ‘e 90mg delta-9 THC ‘i he pepa kotoa 30mL (3mg/mL) — lahi fuka lalo ‘i he fu’u. Kotoa e kānabinoidi ‘oku hemp-derived.

‘Oku ‘ikai ko e delta-9 THC ‘a e THCa. Ko e me’a ‘uluaki ‘oku ‘ikai psychoactive. ‘Oku mahu’inga ‘a e fu’u fakalao: ‘Oku Farm Bill fu’u fakalao ‘a e THCa ‘i he taimi ‘o e fakatau tanu ‘oku ‘ikai ke fakasoa’i ki he delta-9 THC.

‘Oku pule’i ‘e koe ‘a e faka’uli. Fu’u veveli ‘a e ‘ela ‘i he 260°F (125°C) ‘i he minute e 45-60, pea 1,500mg THCa ‘e hoko ‘e ~1,315mg delta-9 THC. Fakafufu mo e 90mg = ~1,405mg delta-9 THC fakakatoa. ‘Oku fakahā ‘eni ko ha me’angaue ‘e taha ‘oku lava ke ngaue ‘o ha anti-inflammatory ‘ikai psychoactive pe veve psychoactive lahi, ‘i ho’o fili he taimi ‘o mui.

Vakai’i Fakavaha’apule’anga Ki He Tongá

Te mā’onau vakai’i fakavaha’apule’anga mo ‘oku mau vakai’i ki he ngaahi fonua ‘e lahi ‘i mamani. Tá ‘ene me’angaue ‘oku ‘i ai ‘e fu’u lahi ‘o 0.3% delta-9 THC ‘i he taimi ‘o e fakatau, ‘oku ne fu’u fu’u fakalao ‘i he fu’u fakalao ‘o e Farm Bill 2018, ‘oku ne lava ke vakai’i ki he ngaahi fonua ‘oku ‘iai e ngaahi fu’u fakalao fakafekiki.

Ki he kakai Tonga:

• Kotoa e pausi fakavaha’apule’anga ‘oku ‘i ai:
  • COA fakakatoa (Certificate of Analysis) ‘oku fakahā ‘a e kotoa ‘o e kānabinoidi
  • Dokumenti ‘oku fu’u fakalao ‘o e Farm Bill
  • Invoice fakapa’anga ‘oku fakahā ‘a e me’angaue “hemp-derived cannabinoid oil, <0.3% delta-9 THC”
  • Sētifiki phytosanitary ‘okú ke fiema’u ‘e he custom ‘o Tonga
• ‘Oku fiema’u ‘e keke ke fakapapau’i ‘a e fakalao ‘i Tonga pea ke tali kotoa e riski fakacustoms/fakalao
• Fēfē ki mā’onau: (832) 416-2816 pe [email protected] ke fakahokohoko’i ‘a e logistics vakai’i ‘i Nuku’alofa pe ngaahi motu kehe

Fakamā’u fakatonutonu: Ko e THCa ‘e fakasoa’i ki he delta-9 THC ‘okú ne fu’u veveli. Ko e kakai ‘oku fiema’u ke fakamahino’i mo fakamālō ‘a e ngaahi fu’u fakalao ‘o Tonga ki he ngaahi me’angaue hemp-derived. Te mā’onau vakai’i fakafepaki, ka ‘oku ke tali kotoa e riski ‘o e customs mo e fakalao. ‘Oku ‘ikai ke fiemi’u ‘e mā’onau fu’u me’angaue ‘i he fonua ‘oku fakamā.

Fu’u fakalao ‘o Tonga ‘i he taimi ni: ‘Oku ‘ikai fu’u fakalao ‘a e kāniva ‘i he Narcotics Act 1967 ‘o Tonga. Ka ko e ngaahi me’angaue hemp-derived ‘oku lisi ‘a e fu’u ‘oku fu’u vaha’a keli. Te mā’onau tokoni ke fesili’i fakataute pe kaule’a Tonga ‘oku ‘ilo ‘a e polisi fakalao ‘i mua ‘o ke fakatau. Ko e Pacific Islands Forum ‘oku lolotonga fakahokohoko ‘a e fo’u fakalao ‘o e veve, pea ‘oku liliu e ngaahi fu’u ‘i ‘Oceania. Ko mā’onau dokumenti ‘oku fakahā fakahā fakato’o ke fakavakai’i ‘e he kau custom.

Vakai’i Ma Maau: Fakahoko ‘a e OilWell RSO Ki Ho’o Fale ‘i Tonga

Fu’u Vakai’i Fakavaha’apule’anga ‘a Mā’onau

‘Oku mau vakai’i ‘i he ‘aho tatau ‘i Houston (fu’u vakai’i ta’etotó ‘i he ngaahi fakavahe ‘o Texas, ‘o kau ai ‘a ho’o vakai’i ta’etotó ki he Texas Medical Center, ‘a ia ‘ko e fakamā me’alelei lahi taha ‘i ‘Amelika), ka ‘oku mahu’inga ‘a mā’onau fu’u vakai’i fakavaha’apule’anga ‘i Tonga.

Ki he fakatau ‘o Tonga:

• Fakahoko: Kotoa e fakatau ‘e fakahoko ‘i he ‘aho ngaue 1-2 mei mā’onau koloa ‘i Houston
• Dokumenti: Kotoa e pausi ‘oku ‘i ai:
  • COA fakakatoa (Certificate of Analysis) ‘oku fakahā a e kānabinoidi
  • Dokumenti ‘oku fu’u fakalao ‘o e Farm Bill
  • Invoice fakapa’anga ‘oku fakahā a e me’angaue “hemp-derived cannabinoid oil, <0.3% delta-9 THC”
  • Sētifiki phytosanitary ‘oku fiema’u ‘e he custom ‘o Tonga
• Kautaha vakai’i: Te mā’onau ngaue’i ‘i he USPS International, FedEx International, pe DHL ‘i he fu’u ‘o e totó mo e fakatonutonu ‘i ‘Oceania
• Taimi ‘o e voyage: Fu’u lahi ‘i he ngaue ‘e 10-20 ‘i Nuku’alofa, fakatefito ‘i he fakahoko ‘o e custom
• Fakamā: ‘E fu’u fakamā ‘i he 24 houa ke vakai’i ho’o pausi
• Pausi fakamā: ‘Oku ‘ikai ‘i ai ha branding kāniva ‘i he pausi tu’a — pausi vāvā mo e “O.W. Distribution, Houston, TX”

PANDEM1C SEO Technology

Ko mā’onau proprietary PANDEM1C SEO (14 million locations, 300+ AI models) ‘oku fakahuhu’i ‘a e faka’ila fakahū fakakolosi ‘i he fu’u lahi ‘a mamani. ‘Oku fakahā ‘eni ‘okú ne, ‘okú ke liliu “cannabis oil for chronic pain” pe “RSO Tonga” ‘i he ‘initanéte, ‘e lava ‘e mā’onau fakamatala fakamahino’i ke a’u atu koe ‘i he fu’u lahi ‘o e taimí.

Fu’u Fakatau ‘i Tonga

Fu’u 1: ‘Alu ki he peisi RSO Guide: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Fu’u 2: Filí ho’o me’angaue:

• ‘Ela Heke RSO (30mL, 16,590mg kānabinoidi fakakatoa) — $129.99
• Vape Cartridge RSO (1g) — $49.99
• Pe ko e kotoa pe he fu’u ngaue

Fu’u 3: Fakafuofua ki he kato mo fakatau. ‘E fu’u ‘i ai ‘a e fu’u vakai’i fakavaha’apule’anga.

Fu’u 4: Fu’u fakamatala fakatonutonu fakacustoms. Te mā’onau tokoni ke fakahā ho’o tu’asila Tonga fakakatoa ‘o kau ai ‘e he hingoa ‘o e motu (e.g., “Vava’u Island, Kingdom of Tonga”).

Fu’u 5: ‘E fu’u ‘e ke ha fakamā ‘i he 24 houa. Vakai’i mo fesili’i fakatefito.

Fu’u 6: ‘I he’ene a’u ‘i Tonga, ‘e fiema’u ‘e he custom ke vakai’i. Ko mā’onau dokumenti ‘oku fakahā ‘a e Farm Bill compliance. ‘Oku ke tali e me’a kotoa ‘o e customs.

Ngaue totó: Te mā’onau tali ‘a e ngaahi kāti fakateletónika fakavaha’apule’anga, PayPal, mo e cryptocurrency ki he kakai Tonga. ‘Okapau ‘oku ke ‘i ai ha palopalema leva, imeli [email protected] pea te mā’onau ngaue’i ma’okau.

Fu’u Tui Faka-Tonga: Faka’apa’apa’i ‘a e Faka-Tonga

‘Oku te mahino ‘oku fiema’u fakatonutonu ke faka’apa’apa’i ‘a e anga faka-Tonga ‘i he fakahoko ‘o e veve fakanapisi ki he Tonga:

Kainga Mo E Kainga (Extended Family)

‘Oku ‘i he anga faka-Tonga, ‘oku fiema’u ‘a e kainga kotoa ke fakahokohoko he ngaue. Ko mā’onau fu’u tataki fakafepaki ‘oku faka’apa’apa’i ‘eni — ‘okú ne, ‘okú ke lava ‘e ha taha ‘i he kainga ke fakatau ‘a e me’angaue, ‘e fakafufu ‘e ia ‘a e mele mo kinautolu ‘oku nau lava ke hanga ‘a e me’angaue. Te mā’onau fakalifí ke fakafehuhu’i ‘i ho’o kainga, tatau mo e fu’u tataki ‘a Simpson.

Faka’apa’apa (Faka’apa’apa) Ki He Anga Tukufakaholo

‘Oku ‘i ai ‘a e ‘ilo fakakatoa ‘o e vai faka’ofá ‘i Tonga. Te mā’onau fu’u fakanapisi ‘oku ‘ikai ko ha me’a ke fakalele’i, ka ko ha me’a ‘oku fu’u — ha vai faka’ofá fakafou ‘oku fu’u ki ho’o ngaahi veve tukufakaholo. Ko mā’onau fu’u tataki ‘oku fakatonutonu ‘e ‘alu ‘i he ‘ilo mo e ‘ilo ‘o e taha.

Tōtōnū (Balance)

Ko fomuā kānabinoidi ‘e toko fitu ‘oku faka’apa’apa’i ‘a e tōtōnū — ‘ikai ko ha kānabinoidi taha ‘oku mahu’inga, ka ko ha fakahokohoko ‘o e kānabinoidi ‘e toko fitu mo e tēpeni ‘e toko fitu ‘oku a’u ki he tōtōnū. ‘Oku tatau mo e anga faka-Tonga ‘o e tōtōnū ‘i he mo’ui, kainga, mo e fakatonutonu.

Moana Mo E Vakai’i

Tatau mo ho’o koʻhina ‘oku vakai’i ‘a e Moana Pasifiki ‘i he ngaahi fetu’u mo e ngaahi au, te mā’onau tokoni ke vakai’i ‘a e fu’u lahi o e kānabinoidi ‘i he ngaahi faitotonu mo’oni, ngaahi faitotonu fakamahino’i, mo e ngaahi me’angaue fakatonutonu (mā’onau ngaahi vakai’i fakakolosi). Te mā’onau faka’apa’apa’i ho’o fu’u taha mo ‘e fakahā ha ngaue ‘o tokoni’i, ‘ikai ‘e fakahokohoko’i.

Nga’utupe Mo E Maau

Lahi ‘a e kainga Tonga ‘oku ma’u ‘a e nga’utupe mei he ngaahi kainga ‘i US, Nu’usila, pe ‘Aositēlelia ‘okú ne fu’u fakalao ‘a e fakanapisi. Ko mā’onau ngaahi fomuā fakafepaki ‘oku fakahā ‘e, ‘oku lava ke fakavavevave ‘e he kainga ‘i tu’apa ‘a e mele mo e fakamatala fakatomuá, ‘ikai ko e me’angaue pe, ‘oku fu’u toʻoké.

Fu’u Fakavakai’i: Ko e OilWell Mei He Ngaahi Me’angaue ‘O Tonga?

OilWell vs. Black Market RSO ‘i Tonga

Fakafekiki	Black Market Tonga RSO	OilWell Formulated RSO
Fakatonutonu	Vai ‘oku ‘ikai ‘ilo, ‘ikai ke vakai’i	‘Oku ‘ikai ke ‘i ai vai, vakai’i fakakolosi
Fu’u lahi	‘Ilo ‘ikai, veveli	553mg/mL fakatonutonu’i, COA-fakapapau’i
Fakalao	‘Ikái, riski ‘o e fakamā	Hemp-derived, dokumenti ‘oku fu’u
Fakatonutonu’i	‘Oku kehe ‘a e ngaue	Formula ‘oku tatau ‘o kotoa
Tokoni	‘Ikái	Tokoni fakatefito, (832) 416-2816
Fakamahino’i	Fu’u tala pe	Fakatonutonu ‘eni, cite ‘e 29
Totó	‘Ilo ‘ikai, ‘oku lava ke si’isi’i	$129.99, ka fu’u fakatonutonu mo fakahā
Fu’u me’a ke hanga	Riski fu’u ngaue	Formula fakafepaki ki he ngaue ‘oku malu’i

OilWell vs. Ngaahi Me’angaue CBD Fakavaha’apule’anga

Lahi ‘a e ngaahi me’angaue CBD fakavaha’apule’anga ‘oku fakatau ‘e 1,000-2,000mg kānabinoidi fakakatoa. Ko mā’onau ‘ela heke ‘oku ‘i ai 16,590mg kānabinoidi fakakatoa — lahi ‘i he 8x ‘a e me’angaue lolotonga. Te mā’onau ‘ikai pe ke fakatau CBD; te mā’onau fakahoko ha fu’u kānabinoidi kotoa.

Fu’u Tā Fakamahino’i Ki He Ngaue Tonga DIY

‘Okapau ‘oku ‘ikai ke lava ‘e ke fakatau mei mā’onau ka ‘oku ma’u ha fu’u kānabinoidi ‘i he fu’u vaha’apule’anga pe ‘i he taimi ‘o ke fakaloloa, ‘e lava ‘e keke hanga ‘a ho’o vā ‘i he mā’onau fomuā fakafepaki. ‘Oku faka’apa’apa’i ‘eni ‘a e fu’u tataki ‘a Simpson mo e tui faka-Tonga.

Fu’u tā faka-Tonga DIY:

1. Tu’u ki he kānabinoidi ‘i ha taha: CBD, CBG, delta-8 THC, THCa, delta-9 THC (‘okú ne fu’u fakalao), CBN, CBC
2. Fu’u ‘i he fu’u fakamahu’inga’i ‘i he taula
3. Fu’u ‘i MCT oil ‘oku ‘ikai ke toe faka’iloa’i ke fakahoko 553mg/mL
4. Fu’u tēpeni cannabis-derived ‘i he 5% (‘okú ne ma’u)
5. Fu’u ‘i pepa sila kula ‘oku ‘ikai ke ‘i ai mama ‘i he veveli mo e hu’u ‘o Tonga
6. Label fakakatoa ‘i he lahi ‘o e kānabinoidi mo e fakamā’u

Fakamā’u fakatonutonu ki he DIY: ‘Oku ‘ikai ke vakai’i e fu’u lahi mo e malu’i ‘okú ‘ikai ke vakai’i fakakolosi. Ko ‘eni ko e fu’u te mā’onau tokoni ‘i he me’angaue ‘oku vakai’i ‘okú ‘ikai fu’u mo’oni.

Fakamatala ‘Ongo: Fakapapapui ‘E He Mētiā ‘E Taha

Ko mā’onau ngaahi fakaha’atau ‘e toko fitu ‘a ABC13 (2019-2023) ‘oku ‘iai e ngaahi ‘atakai ‘oku fakahokohoko’i, fakatonutonu’i, mo fakapapaui ‘e he ABC affiliate ‘oku lolotonga fakahā ‘a Colin Valencia ‘o ‘uluaki taha houston ‘i he ‘ilo fakanapisi. ‘Oku ‘ei fu’u taha ‘e taha te ne lava fakataú.

Ki he kakai Tonga, ko e fakapapapui ‘eni ‘e he mētiā houston ‘o Amerika ‘oku fu’u fiti foki ‘o ‘ene fu’u talanoa ‘oku vakai’i ‘e he kau ‘ātita fakamongamonga. ‘Oku lava ke fakavahevahe’i ‘e koe ‘a e ngaahi fu’u fakaha’atau ‘i ABC13 houston website.

Fu’u Fu’u ‘O Fā ‘A Mā’onau Fomuā

Kotoa e kānabinoidi mo e tēpeni ‘i mā’onau fomuā ‘oku fakapupula’i ‘i he ngaahi fu’u fakamo’oni ‘i he ‘ulungaanga. Ko mā’onau peisi RSO Guide (https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/) ‘oku fu’u tala fakamo’oni ‘i he ngaahi me’angaue, pea ko e fakamatala ‘eni ‘oku fakahā ‘a e fu’u fakamahino’i — cite fakakolosi kotoa, fu’u fakamahino’i, fu’u fakatonutonuí.

‘Oku mā’onau tataki ‘o mā’onau fu’u fu’u fakamahino’i ‘i he fu’u fakamahino’i ‘oku mau vakai’i ‘i he fu’u lahi. ‘Oku ‘ikai ke mā’onau ‘ave fakavāvā mei he vakai’i. Ko e fu’u toke ‘eni ‘a mā’onau ki he kakai Tonga: ‘e fu’u fakahoki ho’o fakamatala fakakatoa ke vakai’i ho’o me’angaue mo ke ke fili.

Fu’u Fakahokohoko: Fu’u Talitonu Ki He Tongá

Mei he fakataha’anga ‘o Montrose ‘i Houston ki ho’o fale ‘i Nuku’alofa, mei he Texas Medical Center ki Vaiola Hospital, mei he talanoa ‘o Bentley ki ho’o fu’u taha ‘o e kainga — ‘oku te mahino ‘e mā’onau, Tonga. ‘Oku mā’onau faka’apa’apa’i ho’o anga fakakatoa, ho’o ngaahi palopalema, mo ho’o totonu ke fai ‘a e ngaahi fili fakamahino’i.

‘Oku ‘ikai ke mā’onau fakatau atu ha vai mo’oni. ‘Oku ‘ikai ke mā’onau fakatau ha toe ‘ofa. Te mā’onau fakahō atu ho’o fakamatala fakakatoa mo e fomuā fakafepaki taha, mo e me’angaue malu’i taha, mo e fu’u fakamahino’i taha.

Fu’u fetau’aki ki he kakai Tonga:

• Telefoni: (832) 416-2816 (foki pe WhatsApp)
• Imeli: [email protected]
• Saiké: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

‘Oku mā’onau tali fakatefito. ‘Oku ‘ikai ke mā’onau fakafefie ‘i he kupu fakakautaha. ‘Oku mā’onau mahino ‘a e palopalema ‘o e maau ki ha me’alemei lahi ‘i he vaha’a ‘o Tonga, pea te mā’onau tokoni ke fakavakai’i ‘a e veve fakanapisi ‘i he fu’u fakatonutonu’i.

‘Oku ‘i ai ‘a mā’onau fu’u fakahō: ‘Oku lahi ‘e he me’angaue — ‘oku ‘fu’u toke’. Pea mei he taha kainga ‘oku talitonu ‘i he kainga, fa’ekausi, mo e ngaue mo’oni ki he taha, te mā’onau faka’apa’apa’i ‘a e fu’u toke ‘eni kiate koe.

Fakamā’u fakatonutonu mo e kakai Tonga:

‘Oku ‘ikai ke fiemi’u ‘e ngaahi me’angaue ‘eni ki he taha ‘oku ta’u si’isi’i pe ‘i lalo ‘o e 21. ‘Oku ‘ikai ke vakai’i ‘e he FDA e ngaahi fakamatala ‘eni. ‘Oku ‘ikai ko e me’angaue ‘eni ke fakamo’oni’i, fakafoki, fakafekiki, pe fakamā e ngaahi veve. ‘Oku fiema’u ke tali ‘e he fakataute fakalao ‘i mua ‘o ke ngaue’i ngaahi me’angaue kānabinoidi, fu’u lahi ‘okú ke veve, fiema’u veve kehe, ‘okú ke fu’u pe tokoni’i, pe ‘okú ke fiema’u fakamāló. ‘Ouá ke ngaue’i ngaahi me’a fakato’onga pe ngaue ‘i he fu’u ‘o e kānabinoidi psychoactive.

‘Oku ke tali kotoa e fu’u fu’u fakalao ‘i Tonga ‘i mua ‘o ke fakatau. ‘Oku ‘ikai ke fiemi’u ‘e OilWell Cannabis LLC fu’u fu’u palopalema ‘o e customs pe fakalao ‘okú ne hoko ‘i Tonga. Kotoa e kakai fakavaha’apule’anga ‘oku tali kotoa e fu’u fu’u fakalao fakalotofonua. ‘E kehe ‘a e me’angaue ‘i he fonua ‘oku fakamā.

ENGLISH

The Complete Guide to Rick Simpson Oil (RSO) for Tonga: Understanding OilWell Cannabis’s Multi-Cannabinoid Formulas

Kia ora, Tonga — A Message from Houston to the Friendly Islands

We see you, Tonga. From our home in Houston’s Montrose neighborhood to your beautiful islands scattered across the Pacific — Tongatapu’s bustling markets, Vava’u’s serene harbors, Ha’apai’s quiet atolls — we understand that communities everywhere deserve honest access to plant medicine that respects both tradition and science. We’re OilWell Cannabis, and we’ve spent years building something that we believe can genuinely help people: formulated Rick Simpson Oil that honors the original vision while solving its problems through modern precision, transparency, and safety.

This isn’t just another product page. It’s the most comprehensive RSO education resource we’ve ever created, specifically crafted for you in Tonga. Whether you’re in Nuku’alofa caring for a family member with chronic pain, a Tongan diaspora member in the US searching for options to send home, or someone on Vava’u exploring natural alternatives when the clinic in Neiafu can’t provide all the answers — this guide is for you. We’ll walk through everything: the real history of Rick Simpson (not the myth), how a paralyzed dog named Bentley changed everything, the exact science behind our seven-cannabinoid formulas, and most importantly, how this all relates to your life in Tonga.

We write this with deep respect for faka-Tonga — the Tongan way of community, family, and respectful decision-making. We won’t sell you hope. We’ll give you the best possible version of the information so you can decide what’s right for you and your kainga.

Understanding Rick Simpson Oil: The Real Story, Not the Legend

Who Was Rick Simpson, Really?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor. He wasn’t a scientist. He was a power engineer and maintenance worker — a blue-collar tradesman whose journey into cannabis began because the medical system failed him, something that resonates across cultures and oceans, including here in Tonga where many of our own people have experienced similar frustrations with limited healthcare options.

In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that doctors couldn’t resolve. The medications they prescribed either didn’t help or made things worse. Cannabis provided relief, but when he asked his physician to support or prescribe it, the request was refused . This pattern — of patients finding relief where conventional medicine falls short — is something we hear from Tongan customers who tell us about loved ones on Tongatapu suffering after accidents or chronic conditions that Vaiola Hospital’s limited resources can’t fully address.

Simpson’s interest deepened after learning about a 1974 NIH-funded study at the Medical College of Virginia, where THC reportedly slowed or shrank tumors in mice. That study was actually designed to demonstrate harm, and its findings were never replicated in controlled human cancer trials . This is the first place where myth and fact separate — and it’s crucial for Tongan readers to understand this distinction, especially in a culture that values honest storytelling.

The pivotal moment came in 2003. Three bumps on Simpson’s arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. Important context: No independent medical verification of this outcome has ever been published. No biopsy confirmation. No clinical follow-up in any peer-reviewed source . This is personal testimony, not medical evidence — but it’s historically significant as the catalyst for a global movement.

The Crusade: From Personal Experiment to Global Movement

After his 2003 experience, Simpson committed himself to making and giving away concentrated cannabis oil from his property in Maccan, Nova Scotia. He charged nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia . He believed in accessibility — a principle that deeply resonates with Tongan values of community sharing and mutual support within kainga.

His story reached global audiences through the 2005 documentary Run From The Cure, directed by Christian Laurette. Distributed freely online, it became foundational in cannabis communities worldwide — for many, including possibly some in Tonga’s growing online health communities, it was their first introduction to concentrated cannabis oil as medicine .

But Simpson’s advocacy brought legal conflict. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He faced charges for cultivation, possession, and trafficking. Eventually, he left Canada for Europe, continuing his advocacy from Croatia and the Netherlands . This history matters for Tongan readers because it explains why cannabis oil has been underground for so long — and why OilWell’s legal, transparent approach represents such a fundamental shift.

Traditional RSO: What It Actually Was

Traditional RSO was defined by method, not by lab specifications. Understanding what it actually was helps Tongan consumers evaluate what’s being sold locally and why OilWell’s approach is different.

Source material: Single high-THC indica strains, with no standardization. Whatever the grower had available — which in Tonga’s informal market might vary dramatically depending on what grows well in your particular island’s climate and soil.

Extraction solvent: Naphtha (a petroleum-based solvent) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic or carcinogenic compounds. This is a major safety concern, especially in Tonga where lab testing infrastructure is limited and consumers may not know what solvents were used in locally-made products.

Process: Cannabis in a bucket, covered with solvent, agitated, filtered, then evaporated in a rice cooker at high heat. The heat was sufficient to decarboxylate all THCa into THC and destroy virtually all terpenes.

Appearance: Nearly black, thick, tar-like oil with a strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, with minor cannabinoids at whatever ratios the source plant contained — uncontrolled, unmeasured, never lab-verified.

Terpene content: Minimal to none. Destroyed by solvent and heat.

Standardization: None. Every batch was different depending on starting material, growing conditions, solvent purity, extraction technique, and evaporation parameters. No Certificate of Analysis, no cannabinoid quantification, no contaminant screening.

Residual solvent risk: Significant. Without lab testing (which few Tongan DIY producers can access), there’s no way to verify if harmful solvent residues remain in the oil.

Simpson’s Claims vs. The Evidence Record

Rick Simpson claimed RSO could cure cancer and many other diseases. He maintained that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge . Understanding the evidence gap is essential for Tongan readers making informed decisions.

What Simpson was not: He had no formal medical, oncology, pharmacology, or clinical research training. He never conducted or published a clinical trial. His evidence was personal experience and informal testimonials — with no controls, no independent verification, no imaging confirmation, no long-term follow-up, no blinding.

What preclinical literature shows: In vitro studies demonstrate that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition . This research is scientifically interesting but not proof of human cancer cures.

What preclinical literature does NOT show: These findings have not translated into proven human cancer cures. No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer. The gap between in vitro/animal results and human outcomes is vast and well-documented across all oncology research .

Institutional positions:

• U.S. National Cancer Institute (NCI): Acknowledges cannabinoids have been studied for potential anticancer effects in lab and animal models but does not endorse cannabis or cannabis oil as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD for seizures) and synthetic THC analogues for chemo nausea and AIDS wasting are approved [1]
• Health Canada: Never approved RSO for cancer
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite — not cancer cure [1]

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored them. He helped create conditions for legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: Cancer cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven therapies carries genuine harm potential. Delayed or foregone cancer treatment is a documented concern in alternative medicine literature.

Traditional RSO vs. OilWell’s Modern Formulated RSO

This comparison table shows why our approach matters for Tongan consumers who need reliable, safe products:

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain, variable	Multi-cannabinoid blend from multiple sources, standardized
Extraction method	Naphtha or isopropyl alcohol (toxic)	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled, unknown potency	Seven defined cannabinoids at specific ratios, 553mg/mL total
Terpene content	Destroyed by heat	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets, COAs available
Residual solvents	Significant risk with naphtha	Controlled and tested, solvent-free final product
Dosing precision	Approximate “grain of rice” estimate	Measured per mL with graduated dropper (0.1mL increments)
Product formats	Single thick oil only	Sublingual oil + vape cartridge, format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — 1,500mg THCa as separate ingredient
Delta-9 THC exposure	600-900mg/day at peak dosing	90mg total in entire bottle (3mg/mL) — dramatically lower
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted, peer-reviewed citations

The OilWell Story: How a Paralyzed Dog Changed Everything

From McAllen’s Borderlands to Houston’s Medical Center

OilWell Cannabis was founded by Colin Valencia in Houston, Texas — a city more different from Tonga’s islands than imaginable, yet connected by shared values of community resilience. Colin grew up in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The Borderplex is one of the most economically challenged and dangerous regions along the US-Mexico border. McAllen has vibrant culture but limited opportunities outside retail and healthcare. Reynosa is an industrial hub plagued by cartel violence. By age sixteen, after seeing friends killed or imprisoned, Colin had to leave home for good.

Despite the dangers, Colin chose cannabis over harder paths. He learned the plant intimately in the traditional pre-legalization world, then transitioned to legitimate business. Later, he became a formally trained software engineer and did custom development work for Baylor College of Medicine in the Texas Medical Center — one of America’s most prestigious medical institutions. That combination of deep plant knowledge and medical-grade technical precision defines everything we do.

Bentley: The Dog Who Started It All

Our company’s origin story begins with a dog named Bentley. Bentley wasn’t just a pet — he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, a rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question exposed a blind spot that would become a mission.

Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It was hope, and hope delivered the impossible: Bentley got up, walked over, and brought his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo — this was real.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

We published Bentley’s original CBD golden paste recipe for free so any Tongan pet owner facing a similar crisis can make it themselves:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 tsp freshly ground black pepper
• CBD oil (dosage depends on pet size; consult a veterinarian)

This open-source pattern — sharing what saved Bentley before we ever sold products for people — is the moral foundation of OilWell.

Colin’s Personal Journey: PTSD, Benzo Addiction, and Recovery

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, we also offer Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, doctors began using our formulas for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. We’ve developed custom formulations for vegans, diabetics, and those with specific health needs — because in Tongan culture, caring for everyone’s unique needs within the community is fundamental.

Seven ABC13 Features: Houston’s Media Validates Our Approach

Between September 2019 and April 2023, ABC13 Houston featured Colin and OilWell in seven news segments. Five different reporters sought us out. No other Houston cannabis operator matches this frequency or breadth.

September 15, 2019 — CBD Business Boom: Our foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot.”

March 22, 2021 — Decriminalization: Colin’s therapy quote: “Pain comes in a lot of different forms.” We helped entrepreneur Jonathan Pina launch his mobile cannabis business, demonstrating our ecosystem-building approach.

May 24, 2021 — Delta-8 THC: Steve Campion’s iconic exchange: “Why would someone want to smoke that?” Colin: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* Uncensored honesty on mainstream TV.

August 20, 2021 — COVID Vaccine Giveaway: We donated 1,000 caviar pre-rolls (~$35,000 in product) to encourage vaccination. We coordinated with the city of Houston — no political agenda, just community health.

October 19, 2021 — Delta-8 Ban: When Texas classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and tried to warn other operators who were unknowingly shipping Schedule I narcotics. We absorbed major revenue loss to act ethically.

October 7, 2022 — Biden Marijuana Pardon: Colin revealed his personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything. I would love to see people not get hurt for this anymore.” This personal history makes every prior quote more powerful.

April 21, 2023 — 4/20 Renaissance: Colin growing hemp on camera: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

These features cannot be purchased — they can only be earned. For Tongan readers, this mainstream media validation from America’s fourth-largest city establishes credibility that transcends geography.

Our Operations: Real Business, Real Standards

We operate from 810 Richmond Avenue, Houston, TX 77006 in the Montrose neighborhood. Since 2019, we’ve generated approximately $1M annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. All artwork, formulations, and packaging are created in-house in Houston using only our own recipes.

We bring Houston grit and McAllen roots, but our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone. That honesty is what you deserve in Tonga.

The OilWell RSO Philosophy: Four Core Principles

Our approach diverges from traditional RSO in deliberate, evidence-motivated ways:

1. Accessibility Over Gatekeeping

No medical card required. Anyone age 21+ can purchase. We ship nationwide across the United States and internationally to customers who verify local legality, including Tonga. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally.

For Tongan customers, this means:

• No need to navigate complex medical systems when specialist care is limited
• Direct access from Nuku’alofa, Vava’u, or anywhere in the Kingdom
• No gatekeeping by institutions — we trust you to make informed decisions for your kainga

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry, not rhetoric.

Three usage options from one product:

• Raw, no heat: All 1,500mg THCa stays non-psychoactive — perfect for daytime functional use in Tonga’s warm climate when you need to work, drive, or care for family without impairment
• Fully activated, home decarboxylation: Heating at 260°F (125°C) for 45-60 minutes converts 1,500mg THCa → ~1,315mg delta-9 THC. Combined with existing 90mg delta-9 THC = ~1,405mg total. This achieves potency comparable to traditional illegal RSO, 100% legally
• Vape, auto-decarboxylation: Our vape cartridge instantly converts THCa at 400-450°F, delivering fastest relief for acute breakthrough symptoms

The conversion: 1mg THCa = 0.877mg delta-9 THC after decarboxylation (accounting for CO₂ loss). This means one purchase serves multiple needs — crucial for Tongan families managing tight budgets.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram, every percentage. If you cannot afford our products ($129.99 for sublingual oil, $49.99 for vape cartridge), you can see exactly what the formula contains, source individual cannabinoid distillates, and make your own version.

This echoes Simpson’s free-distribution ethos. He gave oil away and taught people to make it. He never patented his method. We adapted that for the modern cannabinoid marketplace: sell a professionally manufactured, lab-tested, standardized product for those who want it, and publish the complete recipe for those who want to make it themselves.

For Tongan DIY makers and traditional healers who work with plants, this transparency respects your knowledge and autonomy. You can adapt, refine, and share within your community according to local needs.

4. Evidence-Informed, Not Evidence-Overstating

This entire document represents our commitment to honest education about what science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated. Every claim we make is anchored to specific peer-reviewed citations with evidence strength clearly labeled [1]-[29].

The Science: Understanding Cannabinoids and Terpenes

Evidence Hierarchy: How We Evaluate Research

We prioritize sources in this order: human clinical evidence first, then systematic reviews and meta-analyses, then NIH and institutional summaries, then mechanistic or preclinical literature when human data are sparse. This matters because the evidence base is unevenly distributed.

For Tongan readers, this approach helps you navigate the flood of cannabis information online — much of it hype from US or Canadian sources that doesn’t apply to your context. We anchor every claim to actual science, not marketing.

Cannabinoid Profiles: What Each Compound Does

CBD (Cannabidiol) — 4,500mg in our sublingual formula

Strongest human evidence in our formula set [1]-[6].

Best supported indication: Purified CBD for certain seizure disorders (Epidiolex FDA-approved) [1][2]. This is the clearest major-example indication acknowledged by institutional literature.

Anxiety: A 2024 systematic review covering 316 participants across eight studies reported statistically significant anxiolytic effects, but authors stressed the clinical sample remains limited and more trials are needed [3]. For Tongans dealing with stress from economic pressures or family responsibilities, this suggests CBD may help, but it’s not a guaranteed solution.

Pain: A 2024 review concluded pain literature is promising but heterogeneous, with trial quality limiting confidence in broad analgesic claims [4]. Given Tonga’s limited pain specialist access, CBD offers a potential option, but realistic expectations are essential.

Sleep: A 2023 insomnia review found literature remains methodologically weak, with many studies relying on subjective measures [5]. If you’re in Ha’apai struggling with sleep due to chronic pain, CBD might help, but it’s not a proven sleep cure.

Safety concerns: A 2023 meta-analysis found real signals for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug-drug interactions [1]. If you’re taking other medications (common in Tonga’s older population), consult a healthcare provider first.

CBG (Cannabigerol) — 3,000mg in our formula

Mostly review-level and preclinical evidence [7][8].

CBG is the biosynthetic precursor to several major cannabinoids. It interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling, making it mechanistically interesting but not clinically established [7]. Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses [7][8].

For Tongan readers: CBG is commercially interesting because it’s underexplored, which means claims often outrun the science. We include it based on plausible mechanisms and Bentley’s neurodegeneration experience, not because human trials prove its efficacy.

Delta-8 THC — 6,000mg in our formula

Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].

A 2022 review concluded delta-8 THC and delta-9 THC have broadly similar pharmacokinetic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity, but appears less potent than delta-9, likely due to weaker CB1 affinity [9].

A 2023 scoping review found the delta-8 evidence base dominated by animal studies, product chemistry, and public-health concerns rather than strong human trials. It noted reports of adverse consequences and emphasized regulatory concerns [10]. The chemistry review notes commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels [11].

For Tongan readers: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity but incomplete human safety characterization. If you’re concerned about impairment (especially in Tonga’s close-knit communities where reputation matters), start with raw THCa formula and avoid decarboxylation until you understand your response.

THCa (Tetrahydrocannabinolic Acid) — 1,500mg in our formula

Important chemically and formulation-wise, but low on direct human therapeutic evidence [12].

THCa is the acidic precursor of THC and may represent a large share of THC-related content in raw plant material. It decarboxylates into THC during heating and can change during storage [12]. THCa itself does not produce psychoactive effects — but only if it stays in acidic form and isn’t substantially decarboxylated [12].

In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these aren’t established human outcomes [12].

For Tongan readers: This is the heart of patient-controlled potency. Use the oil raw (no heat) for daytime functional relief without impairment. Decarboxylate for nighttime or severe symptom management. The choice is yours, not predetermined by us.

Delta-9 THC — 90mg in our entire bottle (3mg/mL)

Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15].

NCCIH identifies THC-containing medicines as relevant to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, and some MS/pain outcomes [1]. A 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation [13].

Classic pharmacokinetics: inhaled THC effects within seconds-minutes, peak 15-30 minutes, taper over hours; oral THC has later onset, later peak, longer duration [14].

Mental health risk: A 2025 review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder, plus concerning signals for anxiety/depression in nontherapeutic settings [15]. This is critical for Tongan communities where mental health stigma already exists — we must be honest about risks.

Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure [1][14][15].

Our approach: We include only 90mg delta-9 THC total — far below Simpson’s 600-900mg/day — while providing convertible THCa for those who want more. This balances therapeutic potential with safety.

CBN (Cannabinol) — 750mg in our formula

Weak human evidence; marketing ahead of data [12][16][17].

CBN is widely marketed for sleep, but clinical support is far thinner than the market suggests. A 2021 review screened 99 human-study abstracts and found no clinical trials using validated sleep questionnaires or polysomnography that could substantiate strong sleep-promoting claims [16]. A 2024 updated review concluded cannabinoid sleep research still doesn’t match real-world use scale [17].

For Tongan readers struggling with sleep: We include CBN based on its reputation and some preclinical rationale, but we won’t overstate the evidence. At 750mg per bottle, each mL provides 25mg CBN — above the 20mg threshold associated with reduced sleep disturbance in limited research, but not a guaranteed sleep cure.

CBC (Cannabichromene) — 750mg in our formula

Emerging, intriguing, overwhelmingly preclinical [18][19].

A 2024 focused review argues CBC has distinct pharmacodynamics and highlights antinociceptive, antibacterial, and anti-seizure areas as interesting research targets [18]. Older literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, and possible neurobiological relevance [19].

Safety caveat: The 2024 review explicitly notes over-the-counter CBC products are sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line: CBC is scientifically credible but clinically immature. We include it based on formulation experience with Bentley’s dementia, not because human trials prove its efficacy.

Terpene Profile: The Aromatic Dimension

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Our formula includes 5% live terpenes with a defined seven-terpene profile:

Limonene (citrus-bright)

Multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective properties — mostly from nonhuman/non-cannabis literature [21]. Safety note: limonene oxidation products are contact allergens [22].

Myrcene

Anxiolytic, antioxidant, anti-inflammatory, analgesic properties described in preclinical work, but human studies lacking [23]. Common claim that myrcene causes sedation/is responsible for “couch-lock” is stronger than current evidence supports.

Beta-Caryophyllene (pepper/spice)

Most mechanistically interesting terpene — selective CB2 receptor agonist, making it pharmacologically relevant alongside cannabinoids [24]. Anti-inflammatory, immunomodulatory, neuroprotective properties discussed, but human clinical confirmation limited [24].

Pinene (forest-fresh)

Antioxidant, anti-inflammatory, neuroprotective signals justify future study, but well-designed clinical trials lacking [25]. Claims about memory enhancement or countering THC cognitive effects remain hypotheses, not settled facts.

Linalool (floral, lavender)

Stress, mood, and brain-health pharmacology discussed in reviews [25][26], but dominated by preclinical data. Oxidized linalool hydroperoxides are recognized allergens [22].

Humulene (earthy, woody)

Promising preclinical literature with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27], but not yet clinically settled.

Terpinolene (piney, fruity, sparkling)

Least clinically characterized terpene in our profile. Evidence base dominated by in silico, in vitro, and animal studies [28].

For Tongan readers: These terpenes create our product’s sensory experience — the bright citrus notes of limonene, the familiar forest scent of pinene that might remind you of Tonga’s own pine forests on ‘Eua, the peppery warmth of caryophyllene. While therapeutic claims remain conservative, the aroma and flavor contribute to the holistic experience of the medicine.

Research Limits and Interpretation: Being Honest With You

We need to be straight with our Tongan family about what we know and don’t know:

1. Evidence is highly uneven. CBD and delta-9 THC have the strongest human data; delta-8, THCa, CBG, CBN, CBC, and terpenes depend more on reviews, animal work, and pharmacology [1]-[29].

2. Extract/molecule/synthetic/terpene data aren’t interchangeable. One common error is letting evidence from one category stand in for another. We don’t do that.

3. Minor cannabinoids are commercially interesting BECAUSE they’re underexplored, which means claims frequently outrun the science. We resist that temptation.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, and dose variability all affect real-world outcomes [1][10][11][14]. Our third-party testing addresses this.

5. THCa chemistry changes with storage and heating. The molecule you start with may not be the molecule you end with — important for Tonga’s tropical climate where storage conditions vary [12].

Common Overstatements We Avoid

• Overstatement: CBN is a clinically proven sleep cannabinoid. Truth: Sleep evidence for CBN remains weak with no strong trial base [16][17].
• Overstatement: Myrcene makes you sleepy/causes couch-lock. Truth: Human proof for this common claim is limited [23].
• Overstatement: Terpenes have proven entourage effects. Truth: Robust clinical proof remains limited [20][29].
• Overstatement: THCa is always non-psychoactive. Truth: Heating converts THCa to THC, changing effective exposure [12].
• Overstatement: Delta-8 THC is safe because it’s hemp-derived. Truth: Delta-8 is psychoactive with incomplete safety characterization [9]-[11].

Our RSO Formulas: Complete Transparency

RSO Sublingual Oil — $129.99

Cannabinoid	Amount	Purpose
CBD	4,500mg	Foundation cannabinoid, anxiolytic, anti-inflammatory
CBG	3,000mg	Neuroprotection, potential GI support
Delta-8 THC	6,000mg	Pain modulation, anti-nausea, psychoactive component
THCa	1,500mg	Patient-controlled potency, non-psychoactive anti-inflammatory option
Delta-9 THC	90mg	Minimal baseline THC, well below legal threshold
CBN	750mg	Sleep support (emerging evidence)
CBC	750mg	Neurogenesis potential, complements CBG
Total	16,590mg	553mg per mL

Additional specs:

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Dosing: Graduated dropper with 0.1mL increments
• Onset: 15-45 minutes (sublingual absorption)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Doses per bottle: Approximately 40-60 depending on serving size

For Tongan dosing context: Starting with 0.25-0.5mL (138-277mg total cannabinoids) allows you to assess effects before adjusting. This is far more precise than Simpson’s “grain of rice” estimate.

RSO Vape Cartridge — $49.99

Cannabinoid	Percentage	Purpose
CBD	30%	Foundation, anxiolytic
CBG	20%	Neuroprotection
Delta-8 THC	15%	Pain, psychoactive
THCa	10%	Auto-converts to THC when vaped
CBN	10%	Sleep support
CBC	10%	Neurogenesis
Live Terpenes	5%+	Aroma, potential entourage effects

Additional specs:

• Format: 1-gram 510-thread cartridge (universal battery compatibility)
• Onset: 1-2 minutes (fastest delivery method)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (dependent on inhalation technique)
• Auto-decarboxylation: Vaping at 400-450°F instantly converts THCa to delta-9 THC

For Tongan users: The vape provides fastest relief for acute breakthrough pain or panic attacks. However, we recognize vaping may conflict with cultural norms or health preferences. The sublingual oil remains our primary recommendation for sustained daily use.

When to Use Each Format: A Guide for Tongan Lifestyles

Use Case	Recommended Format	Rationale for Tongan Context
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset crucial when symptoms strike suddenly
Sustained relief (chronic pain, all-day support)	Sublingual oil	4-6 hour duration matches work days or sleep nights
Maximum bioavailability	Sublingual oil	13-19% absorption gets more from each dose
Portability/discretion	Vape	Compact for travel between islands or to town
Precise dosing control	Sublingual oil	Graduated dropper allows careful titration
Daytime non-psychoactive use	Sublingual oil (raw)	THCa stays inactive — work, drive, parent without impairment
Nighttime psychoactive use	Sublingual oil (decarbed) or vape	Activated for severe symptoms or sleep support

Condition-Specific Guidance for Tongan Health Priorities

Important disclaimer: These contexts are informed by cannabinoid research cited throughout this document. They are not medical prescriptions, not FDA-approved, and not substitutes for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have medical conditions, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

Protocol:

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

Evidence: Delta-8 THC antiemetic effects [9], delta-9 THC for nausea/vomiting [1][13], CBD for anxiety buffering [3]

For Tongan context: Cancer treatment often requires travel to New Zealand or Australia. Our international shipping can deliver to you wherever you are receiving care. The non-psychoactive raw option allows daytime symptom management without interfering with family responsibilities.

Chronic Pain (Arthritis, Neuropathy, Fibromyalgia)

Protocol:

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed

Evidence: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

For Tongan context: Chronic pain is common in agricultural and fishing communities. Limited access to pain specialists makes self-managed options crucial. Our graduated dropper allows precise dosing without the guesswork of traditional RSO.

Sleep Disorders and Insomnia

Protocol:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN (dosage level in 2024 sleep literature)
• At 1.0mL: Delivers 25mg CBN (above 20mg threshold associated with reduced sleep disturbance)

Evidence: CBN sleep evidence [16][17], cannabis and sleep review literature

For Tongan context: Sleep disruption from pain, stress, or shift work (especially in tourism or fishing) affects many. The sublingual oil’s 4-6 hour duration supports full-night sleep. However, we acknowledge CBN evidence remains limited — we include it based on plausible mechanisms, not proven efficacy.

Anxiety, Stress, and PTSD

Protocol:

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0mL sublingual — full profile including CBN for sleep architecture

Evidence: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage effect [20]

For Tongan context: Mental health stigma is real in Pacific communities. Our discreet sublingual oil allows private use without drawing attention. The non-psychoactive raw option means you can manage symptoms while fulfilling community and church obligations without impairment.

Legal Framework: Farm Bill Compliance and International Access

The THCa Legal Innovation

The 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC at the federal level in the US. Our sublingual oil contains only 90mg delta-9 THC in the entire 30mL bottle (3mg/mL) — well under the threshold. All cannabinoids are hemp-derived.

THCa is not delta-9 THC. It is the acidic, non-psychoactive precursor. This distinction is legally significant: THCa is Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC.

You control the conversion. Heat the oil at 260°F (125°C) for 45-60 minutes, and 1,500mg THCa becomes ~1,315mg delta-9 THC. Combined with existing 90mg = ~1,405mg total delta-9 THC. This means the same product can function as non-psychoactive anti-inflammatory OR full-potency psychoactive medicine, entirely at your discretion after purchase.

International Shipping to Tonga

We ship internationally and have delivered to multiple countries across continents. Because our product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill, making it shippable to jurisdictions with compatible hemp laws.

For Tongan customers:

• All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs
• Minimum flat-fee shipping applies; excessive costs are billed to customer
• You are responsible for verifying legality in Tonga and accepting all customs/legal risk
• Contact us: (832) 416-2816 or [email protected] to discuss shipping logistics to Nuku’alofa or other islands

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local Tongan laws regarding cannabinoid products. We ship with full documentation, but you accept all customs and legal responsibility. Our products are void where prohibited by law.

Tonga’s current cannabis law: Cannabis is illegal under Tonga’s Narcotics Act 1967. However, hemp-derived products with minimal THC are a gray area. We recommend you consult local authorities or a Tongan lawyer familiar with drug policy before ordering. The Pacific Islands Forum has discussed drug policy reform, and laws are evolving throughout Oceania. Our documentation provides transparency for customs officials to make informed decisions.

Delivery and Accessibility: Getting OilWell RSO to Your Door in Tonga

Our Global Shipping Infrastructure

While we offer same-day delivery in Houston’s zones (including free delivery to the Texas Medical Center, the world’s largest medical complex), our international shipping capabilities are what matter for Tonga.

For Tongan orders:

• Processing: All orders are fulfilled within 1-2 business days from our Houston facility
• Documentation: Each package includes:
  • Complete product COA (Certificate of Analysis) showing cannabinoid content
  • Farm Bill compliance documentation
  • Commercial invoice describing contents as “hemp-derived cannabinoid oil, <0.3% delta-9 THC”
  • Phytosanitary certificate if required by Tongan customs
• Shipping carriers: We use USPS International, FedEx International, or DHL depending on cost and reliability to Oceania
• Transit time: Typically 10-20 business days to Nuku’alofa, depending on customs processing
• Tracking: Full tracking provided so you can monitor your package’s journey across the Pacific
• Discreet packaging: No cannabis branding visible on external packaging — plain boxes with return address “O.W. Distribution, Houston, TX”

PANDEM1C SEO Technology

Our proprietary PANDEM1C SEO system (14 million locations, 300+ AI models) drives organic search visibility across six continents. This means when someone in Tonga searches “cannabis oil for chronic pain” or “RSO Tonga” in English, our educational content has the best chance of reaching you with honest information rather than hype.

How to Order from Tonga

Step 1: Visit our RSO Guide page: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Step 2: Choose your product:

• RSO Sublingual Oil (30mL, 16,590mg total cannabinoids) — $129.99
• RSO Vape Cartridge (1g) — $49.99
• Or both for complementary use

Step 3: Add to cart and checkout. International shipping options will appear.

Step 4: Provide accurate customs information. We recommend using your full Tongan address including island name (e.g., “Vava’u Island, Kingdom of Tonga”).

Step 5: You’ll receive tracking within 24 hours. Monitor progress and contact us with any questions.

Step 6: Upon arrival in Tonga, customs may require inspection. Our documentation demonstrates Farm Bill compliance. You accept responsibility for any customs duties or seizures.

Payment: We accept international credit cards, PayPal, and cryptocurrency for Tongan customers. If you have issues with international payments, email [email protected] and we’ll work with you.

Tongan Cultural Connection: Respecting Faka-Tonga

We recognize that introducing cannabis medicine to Tonga requires sensitivity to your cultural values:

Community and Kainga (Extended Family)

In Tongan culture, health decisions involve the whole kainga. Our open-source formula philosophy respects this — if one family member can afford the product, they can share the recipe with others who can make it locally. We encourage sharing within your community, just as Simpson originally intended.

Respect (Faka’apa’apa) for Tradition

Tonga has rich traditional plant medicine knowledge. We position cannabis not as replacement but as complement — a modern plant medicine that joins your existing healing traditions. Our evidence-based approach honors your intelligence and existing wisdom.

Balance (Tōtōnū)

Our multi-cannabinoid formula embodies balance — not a single dominant compound, but a symphony of seven cannabinoids and seven terpenes working in harmony. This mirrors Tongan values of balance in life, community, and health.

The Sea and Navigation

Just as your ancestors navigated the vast Pacific using stars and currents, we’re helping you navigate the complex world of cannabinoids with clear maps, honest charts, and reliable instruments (our lab tests and formulas). We respect your journey and offer guidance, not commands.

Remittances and Accessibility

Many Tongan families receive remittances from relatives in the US, New Zealand, or Australia where cannabis is legal. Our open-source formulas mean overseas family can also send the recipe and sourcing information, not just the product itself, making care more sustainable.

Competitive Comparison: Why OilWell for Tonga?

OilWell vs. Black Market RSO in Tonga

Factor	Black Market Tonga RSO	OilWell Formulated RSO
Safety	Unknown solvents, no testing	Solvent-free, third-party tested
Potency	Unknown, variable	Precisely 553mg/mL, COA-verified
Legality	Illegal, seizure risk	Hemp-derived, documentation provided
Consistency	Every batch different	Identical formula every time
Support	None	Direct customer service, (832) 416-2816
Education	Word-of-mouth only	This comprehensive guide, 29 peer-reviewed citations
Price	Unknown, may be cheaper	$129.99, but includes safety and transparency
Option for DIY	Risky extraction	Open-source formula for safe local making

OilWell vs. International CBD Brands

Most international CBD brands sell products with 1,000-2,000mg total cannabinoids. Our sublingual oil contains 16,590mg total cannabinoids — more than 8x the typical product. We don’t just sell CBD; we provide a complete multi-cannabinoid system.

Practical Guidance for Tongan DIY Makers

If you cannot afford our products but have access to cannabinoid distillates through international connections or when traveling, you can make your own version using our published formula. This honors the Simpson ethos and Tongan self-reliance.

DIY instructions for Tongan makers:

1. Source individual distillates: CBD, CBG, delta-8 THC, THCa, delta-9 THC (if legal), CBN, CBC
2. Mix at ratios specified in our formula table
3. Dissolve in organic MCT oil to achieve 553mg/mL total concentration
4. Add cannabis-derived terpenes at 5% (if available)
5. Store in airtight amber glass bottles away from Tonga’s heat and humidity
6. Label clearly with cannabinoid content and safety warnings

Safety critical for DIY: Without lab testing, you cannot verify final potency or purity. This is why we recommend our tested product when possible. However, we respect your right to make your own informed choices.

Media Recognition: Third-Party Validation You Can Trust

Our seven ABC13 features (2019-2023) represent independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as Houston’s most credible cannabis voice. This is the kind of recognition that cannot be purchased — only earned.

For Tongan readers, this mainstream US media validation provides confidence that our claims have been scrutinized by professional journalists, not just marketers. When we say “seven ABC13 features,” you can verify these articles online. When we quote Colin’s statement about his cannabis conviction, you can watch the video segment yourself.

This transparency distinguishes us from anonymous online brands that may ship to Tonga without accountability.

How OilWell’s Formulas Connect to This Evidence

Every cannabinoid and terpene in our formulas is anchored to the evidence profiles above. Our RSO Guide page (https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/) makes specific research claims about individual compounds, and this document provides the source evaluation context — the same peer-reviewed citations, the same evidence-tier assessments, the same cautious interpretation framework.

We hold ourselves to the same evidence standards we apply to the broader field. We don’t exempt ourselves from scrutiny. That’s the promise we make to Tongan customers: you’ll get the best possible information to give our products a fair shot and decide if they’re right or wrong for you.

Closing: Our Commitment to Tonga

From Houston’s Montrose neighborhood to your home in Nuku’alofa, from the Texas Medical Center to Vaiola Hospital, from Bentley’s story to your family’s health journey — we see you, Tonga. We respect your culture, your challenges, and your right to make informed decisions.

We won’t sell you snake oil. We won’t sell you hope. We’ll give you the best possible version of the information, the most transparent formulas, the safest products, and the honest evidence evaluation you deserve.

Our contact for Tongan customers:

• Phone: (832) 416-2816 (call or WhatsApp)
• Email: [email protected]
• Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

We answer directly. We don’t hide behind corporate speak. We understand the challenges of accessing quality healthcare across Tonga’s islands, and we’re here to help you navigate cannabinoid medicine with integrity.

As we say in Houston: this is more than a brand — it’s a promise. And from one community that values family, respect, and honest work to another, we honor that promise to you.

Final Legal Disclaimer for Tongan Customers:

These products are not for use by or sale to persons under 21 years of age. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited by Law. Individual results may vary. Consult your physician before use if you are pregnant, nursing, have or suspect a medical condition, or are taking any medication. You are responsible for verifying legality of hemp-derived products in Tonga before ordering. OilWell Cannabis LLC assumes no liability for customs seizures or legal issues arising from importation into Tonga. All international customers accept full responsibility for compliance with local laws.

---